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Abstract 
Since 2001, well over 2.1 million U.S. military personnel have served during Operation 
Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) 
(Elder, 2015).  During the OEF/OIF/OND era, traumatic brain injuries (TBI) have become a 
hallmark injury of returning veterans in addition to posttraumatic stress disorder (PTSD) and 
chronic pain (Mott, Mondragon, Hundt, Beason-Smith, Grady, & Teng, 2014).  Approximately 
20% of OEF/OIF/OND veterans meet the criteria for having polytrauma and estimates of 6-8% 
have what is known as the polytrauma clinical triad (PCT) which is co-occurring PTSD, TBI, 
and chronic pain (Cifu, Taylor, Carne, Bidelspach, Sayer, Scholten, & Campbell, 2013).  
Numerous randomized clinical trials have shown that cognitive processing therapy (CPT) and 
prolonged exposure (PE), two evidence-based treatments for posttraumatic stress disorder 
(PTSD), are equally effective at improving PTSD symptoms.  The present study aims to shed 
light on predicting clinical outcomes for OEF/OIF/OND veterans with PCT who have engaged in 
CPT or PE.  Whether or not CPT and PE are effective treatments, for veterans with PCT, at 
reducing self-reported PTSD, depression, anxiety, alcohol use, and pain symptoms is measured 
using changes in total scores on the PTSD Checklist Military Version (PCL-M), Beck 
Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Alcohol Use Disorders 
Identification Test (AUDIT-C), and the Defense and Veterans Pain Rating Scale (DVPRS) 
scores. This study was completed via retrospective review of approximately 2,100 electronic 
medical record charts.  The final cohort included in this study was comprised of 140 veterans in 
individual therapy utilizing CPT or PE through the Veterans Health Administration.  Two-way 
RM-ANOVAs and RM-MANOVA were used to analyze the data in SPSS.  Consistent with 
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previous findings, this study found that both CPT and PE are effective treatments for PTSD 
although treatment outcomes varied within and between groups when race/ethnicity were 
considered.  The findings of the current study were consistent with previous literature and 
provide some initial data for understanding PTSD treatment outcomes with veterans with PCT. 
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Since 2001, well over 2.2 million U.S. military personnel have served during Operation 
Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and/or Operation New Dawn (OND) 
(Elder, 2015).  Approximately 15% of those who have experienced combat exposure in Iraq or 
Afghanistan are later formally diagnosed with posttraumatic stress disorder (PTSD) (Sundin, 
Fear, Iversen, Rona & Wessely, 2009).  It is likely that this is a low estimate of the number of 
veterans who experience PTSD symptoms because only 1 in 2 veterans seeks treatment, 
especially those who are older in age or have a minority status (Friedman, 2015).  These facts are 
alarming because of the high association between PTSD and other issues such as suicide, 
substance abuse, interpersonal relationship issues, homelessness, chronic unemployment, chronic 
health problems, substance abuse, early death, and co-morbidity with other mental health 
diagnoses (Bahraini, Breshears, Hernandez, Schneider, Forster, & Brenner, 2014).  When a 
combination of these injuries or disorders occur, it is called polytrauma clinical triad (PCT) and 
one of the most common combinations that veterans have is PTSD, TBI, and chronic pain (Otis, 
McGlingchey, Vasterling, & Kerns, 2011).  
The acts of terrorism that took place on U.S. soil on September 11, 2001 forever scarred 
the face of modern history, but more importantly, became a defining moment that changed the 
lives of many.  On the morning of 9/11, 19 Islamic extremists with ties to al-Qaida, a terrorist 
organization which was headed by Osama bin Laden, hijacked four commercial airplanes.  Two 
of the planes were flown into the Twin Tower’s that had been iconic markers of New York’s 
World Trade Center and skyline.  A third plane was crashed into the Pentagon in Washington, 
D.C., and the fourth plane was destroyed in a field in Shanksville, Pennsylvania only after 
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passengers were able to derail the hijackers from executing their planned mission.  Nearly 3,000 
civilians lost their lives that day with lasting impacts on their family, friends, and an entire 
generation around the globe.   
At the time of the attacks on 9/11, George W. Bush was serving as president and was 
faced with the monumental task of uniting the country in healing and in what became known as 
the War on Terrorism.   Bush described his vision and purpose for the War on Terror that 
asserted that America would “pursue nations that provide aid or safe haven to terrorism. Every 
nation in every region now has a decision to make: Either you are with us or you are with the 
terrorists.”   These sentiments would set the stage for a war that would last over a decade. 
Operation Enduring Freedom (OEF; October, 2001 – December, 2014) is the official 
term used for the War in Afghanistan which falls under the umbrella of separate wars that 
collectively make up what is referred to as the Global War on Terror (GWoT).   Operation Iraqi 
Freedom (OIF; March 2003 - November 2011) and Operation New Dawn (OND; September 
2010 - December 2011) are the names of the other two major conflicts that are also under the 
umbrella of the GWoT.  President Barack Obama and his administration coined the phrase 
“Operation New Dawn” as a reflection of the lesser role that U.S. military forces were to play.  It 
is important to note that the servicemembers involved in the GWoT were all volunteer forces 
meaning that they were not drafted to serve in the wars.  This has important implications because 
it meant that many servicemembers deployed multiple times during their service years which has 
had great impacts on various aspects of their health and functioning.   
Operation Enduring Freedom started with the intentions of apprehending Osama Bin 
Laden, eradicating Al Qaeda, and seizing power from the Taliban.  Spanning approximately 13 
years, OEF is the longest campaign of the U.S. having deployed ground forces.  OIF spanned 
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about 8 years and its initial goal was to find weapons of mass destruction and to capture and 
remove Saddam Hussein.  In December 2003, during Operation Red Dawn, Saddam Hussein was 
captured by American forces and was later found guilty of crimes against humanity as well as 
several other crimes.  Hussein was executed in 2006 and U.S. forces extended their mission in 
OIF to include nation-building and counterterrorism purposes. In late 2010, the Department of 
Defense (DoD) officially named these new efforts as Operation New Dawn. OEF ceased on 
December 28, 2014 under the Obama administration, but a new mission, Operation Freedom 
Sentinel (OFS) continued as well as Operation Inherent Resolve (OIR).  OIR intended to 
continue efforts to resolve issues with military operations in Iraq and Syria involving the Islamic 
State of Iraq and the Levant.  
A large number of OEF/OIF/OND veterans who returned home from deployment(s) face 
many forms of not only physical health issues, but have mental health concerns as well.  One 
2010 study reports finding that about 15% of those exposed to combat in Iraq or Afghanistan 
develop PTSD (Sundin, Fear, Iversen, Rona, & Wessely, 2010). To reiterate, this is likely a low 
estimate of the true number of veterans impacted by PTSD due to the fact that as many as 50% 
of veterans who experience negative mental health symptoms do not seek professional help.  
Thus, many never receive diagnoses or treatments and little is known about this cohort due to 
lack of available data. 
An August 2015 Congressional Research Service Report provides a glimpse into the 
harrowing reality of the toll that the Global War on Terror has had on OEF/OIF/OND veterans.  
Using data available from October 7, 2001 through July 28, 2015 (date range that is closest to the 
dates used in the current study), 6,855 servicemembers died in hostile and non-hostile actions 
and an additional 52,351 were wounded in action.  New annual cases (newly diagnosed) of 
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PTSD between 2000 and June 5, 2015 in servicemembers who had not previously deployed 
totaled 39,264 and in servicemembers who had deployed specifically during 
OEF/OFS/OIF/OND/OIR an astounding 138,197 new cases of PTSD were identified from the 
Defense Medical Surveillance System (DMSS).  During this same time span, a total of 327,299 
new traumatic brain injury (TBI) incidents occurred in deployed and non-deployed 
servicemembers combined with the majority of injuries meeting criteria for being mild, followed 
by moderate, not classifiable, and then penetrating or severe.  All of this information leads to the 
issue at hand that OEF/OIF/OND veterans have unique sets of injuries related to war and many 
are victims of polytrauma.  With large numbers of wounded current era veterans entering the VA 
healthcare system is it crucial to understand the unique needs and experiences of this population.  
Perhaps the most poignant way to convey the striking significance of why studying the 
polytrauma clinical triad in OEF/OIF/OND veterans is critically important is to share the stories 
of those who have carried the burden of PCT.  The first reflection comes from former Army 
Captain Darisse Smith.  Captain Smith was deployed to Iraq from 2005-2006 as a Kiowa 
helicopter pilot. “I lived in pain the entire time that I was deployed. My lower back was hurting, 
mostly due to the vibrations of the aircraft I was flying and inadequate seating.” Four back 
surgeries and one spinal stimulator implant later, Smith continues to struggle with chronic pain.  
Smith described how living with chronic pain led to the development of her PTSD and 
depression, “I swallowed lots of pills - OxyContin, Vicodin, all kinds of opiates - and I just hid 
all the negative emotions I was having. PTSD symptoms started to creep up, and I hid them with 
pills. Depression, thoughts of suicide, plans for suicide, very close to ending my life, and I just 
used pills against it.”  CPT Smith, now a civilian, was able to benefit from receiving effective 
interventions for her pain, depression, and PTSD.  She states that, “I vowed to get the word out 
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about my personal story so that others facing similar troubles could be encouraged and so that 
medical professionals could see the impact of injury and mental illness.”  Smith’s story is not 
unlike thousands of other stories from OEF/OIF/OND veterans that have yet to be shared and 
heard.   
For more than a decade, chronic pain has been the most common reason for OIF and OEF 
medical evaluation.  In a sense, the need to address and relieve chronic pain is what seems to get 
the first foot in the door in many cases of veterans who later acknowledge issues related to 
PTSD, depression, anxiety, suicide, or substance use.  Of veterans that entered the VA system 
between 2005 and 2008, 48% reported chronic pain and spinal pain was the most common area 
of complaint. Although there are many possibly etiologies of chronic pain, there are some unique 
risk factors for members of the military such as carrying heavy packs, consistent high-impact 
physical exertion, being mobilized in combat or training exercises through rough terrain, lifestyle 
factors such as poor sleep, nutrition, stress, and the psychological risks of military service. 
A second veteran’s story of polytrauma is that of Staff Sergeant Ben Ricard.  Ricard’s life 
was changed when the Mine Resistant Ambush Protected (MRAP) vehicle he was driving hit a 
roadside improvised explosive device (IED).   Ricard suffered significant injuries after being 
expelled from his vehicle.  His injuries included two broken legs, a broken arm, a broken back, 
and a traumatic brain injury.  He sought varying levels of treatment and completed his recovery 
process at the Richmond Veteran's Affairs Polytrauma Rehabilitation Center which is one of 
only five designated Polytrauma Rehabilitation Centers nested within the VA healthcare system 
throughout the U.S.  Ricard shared that he found strength in numerous sources during his 
treatment and recovery including his family, military training, and his belief in himself. "I 
gradually got stronger. I was able to stand up. I was able to walk. I was able to hug my wife. I 
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was able to hold my kids. No matter how tough it is, it gets better. That's the toughest thing to 
deal with because it takes time and it takes patience."   
Another Airman’s mother recounted the experience of her son’s non-hostile accident that 
caused him to spend over a year at a Polytrauma Rehabilitation Center, "David's accident has 
definitely colored our life with a different crayon... our life has not gradually changed, it has 
changed instantaneously and permanently."  These sentiments echo the importance of the role 
that effective specialized interventions and polytrauma centers serve, as well as the necessity that 
strong systems of support play in the recovery process for veterans and their families.   
The current study aims to focus on the use of evidence based treatments developed for 
use with patients with PTSD that may have beneficial implications for use with veterans with the 
polytrauma clinical triad.  Because this study specifically utilizes these interventions that target 
PTSD, much of the information discussed will be concentrated on PTSD more so than other 
clinical indictors such as TBI, chronic pain, depression, anxiety, and substance use that will also 
be reviewed.  Previous research has posited that polytrauma patients often experience a wide 
range of mental health symptoms, but when PTSD is present, it is like the driver of the bus and 
the other clinical symptoms are like the passengers that are driven or dictated by the actions of 
the driver (PTSD).  It seems clear that there is often comorbidity and likely shared vulnerability 
between PTSD, chronic pain, and TBI.  It is likely that factors such as sensitivity or tendencies 
towards anxiety and depression mediate and/or moderate the relationship and course of PTSD, 
chronic pain, and TBI.  One recent study of OEF/OIF veterans from a polytrauma rehabilitation 
center found that 42% had the polytrauma clinical triad.  Most notably from this study, it was 
found that it was more common for veterans in the sample to have all 3 diagnoses concurrently 
present than to have any one diagnosis in isolation.  In many complex ways, these sets of 
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symptoms interact with and influence each other and more researcher is needed to understand the 
nature of their relationships.   
Also of significance is the issue that many individuals who endure chronic pain and are 
diagnosed with PTSD endorse higher rates of prescription pain medication abuse as well as use 
of other substances (legal and illegal) to self-medicate or manage their symptoms.  Many recent 
studies are exploring substance use in veteran populations and some have found that current era 
veterans with complaints of pain are significantly more likely to be prescribed opioid derived 
medications and to self-report risky use of such medications.  Of further relevance to the present 
study, veterans who had been diagnosed with PTSD and were prescribed opioid pain medications 
were at higher risk for experiencing accidents, overdoses, and suicide.  There is a clear and 
urgent need for interdisciplinary research and team approaches to clinical interventions to better 
serve veterans of the Global War on Terror.  
Humans who have a history of exposure to traumatic stimuli have noted their experiences 
of PTSD symptoms for thousands of years.  Not surprisingly, those who experience a traumatic 
event are at a higher risk for developing co-occurring issues such as traumatic brain injury and 
chronic pain (Bomyea, Risbrough, & Lang, 2012; Bremner, 2006; Halligan & Yehuda, 2000). 
The phenomenon that we now call posttraumatic stress is not new, but how we approach, study, 
and understand the clusters of symptoms that manifest during in this disorder has evolved rapidly 
over the past century.  Researchers and practitioners have come to recognize that PTSD 
symptoms do not exist in a vacuum.  The symptoms are correlated or connected to how other 
mental health factors influence the quality of life that that PTSD patients experience both daily 
and over their lifespan.  Not only does PTSD affect patients who have experienced trauma, but it 
also has significant impacts on the lives of those who have relationships or interact with them.   
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As part of a concerted effort to better inform practitioners who treat the over 4 million 
veterans who use Veteran Affairs (VA) services, the VA has implemented initiatives to advance 
research and distribute evidence-based treatments (EBT’s) for PTSD.   The two most commonly 
used EBT’s for PTSD include Cognitive Processing Therapy (CPT) and Prolonged Exposure 
(PE).  Briefly, CPT is rooted in Cognitive Behavioral Therapy where clients recount their 
memories of trauma and then come up with more adaptive ways to process their memories and 
reactions to traumatic experiences (Jeffreys, Reinfeld, Nair, Garcia, Mata-Galan, & Rentz, 2014).  
PE was born out of behavioral theories that posit the necessity of re-experiencing traumatic 
memories so that habituation (reduction) of anxiety responses occur (Marks, Lovell, Noshirvani, 
Livanou, & Thrasher, 1998).  Both CPT and PE fall under the umbrella of trauma-focused 
therapies because both require he client to confront their traumatic memories in and out of 
sessions. 
To detail CPT a bit further, it is a manualized approach to working with clients with 
symptoms related to PTSD.  There are currently 9 different ways that CPT may be delivered to 
clients in various forms including individual, group, abbreviated length, and versions that include 
modifications of activities such as written trauma accounts and worksheets.  While it intends to 
assist clients with learning new more adaptive ways to process trauma, it has also been shown to 
be beneficial in relieving other symptoms such as depression and anxiety.   
PE is different from CPT in that it is a distinctly behavioral treatment involving imaginal 
re-experiencing memories of trauma.  The rationalization for this method is that continual 
exposure to the re-experiencing memories of traumatic event promotes habituation which may 
result in a reduction of responses such as anxiety and fear.  Additionally, PE involves some in 
vivo activities that require the patient to gradually resume interactions or activities that they 
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typically avoid because they fear triggering unwanted symptoms.  Patients learn that they are 
capable of managing their symptoms and are able to engage in daily activities with less distress.  
CPT and PE share several common factors.  For example, both approaches are highly 
focused on targeting relief from symptoms connected to traumatic events that the patient has 
experienced.  Therefore, they both are considered to be trauma-focused therapies.  They also 
require the therapist to deliver the treatment in a safe environment while maintaining a positive 
therapeutic alliance.   These treatments both rely on the therapist being able to “sell” the 
rationale for the approaches to patients.  That is to say that the provider needs to be able to 
explain a reasonable justification for why and how these trauma-focused interventions promote a 
change process to occur.  The goals of the patient and therapist should also be in congruence 
with whichever approach is chosen.   
A number of recent studies have found that CPT and PE are efficacious in treating PTSD 
(Benish, Imel, & Wampold, 2008). The outcome data indicate that based on meta-analytic results 
the two therapies both lead to decreases in PTSD symptoms for patients who complete the 
protocols (Bradley, Greene, Russ, Dutra, & Westen, 2005). However, a number of issues have 
been present in the design and methodology used to arrive at the results of many studies. For 
example, many studies have been randomized control trials which took place in highly controlled 
environments that lack the unpredictable nature of real world therapy.   These studies that have 
been conducted in highly controlled settings allow for little variance in participants, therapist 
effects, or other factors that could confine or otherwise influence results in ways that would be 
more analogous to real world clinical settings. Other studies have used small sample sizes or 
very specific subjects in their samples.  Some issues that commonly occur with these types of 
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sampling issues are that that the results become less generalizable or transferable to other 
populations or other settings.   
Because the current study utilizes retrospective data collected in VA settings throughout 
the U.S. and used random selection of patient charts that met inclusion criteria, it increases the 
degree to which the results of this study may match real world settings with real patients of an 
increased number of race/ethnicities, genders, age, types of trauma, and other relevant patient 
level factors.  It is very important that the current study includes an investigation of the 
effectiveness of CPT and PE for patients with different racial or ethnic backgrounds.  A few 
studies have found conflicting information about the effectiveness of both treatments across 
different races or ethnicities (Alvarez, 2011; Walling, Suvak, Howard, Taft, & Murphy, 2012). A 
2014 dissertation by Rutt did look at differences in the effectiveness of CPT and PE across 
racial/ethnic categories and found that “older veterans and Hispanic veterans had higher PCL 
scores at baseline.”.  Rutt (2014) further noted that “veterans across all three racial/ethnic groups 
(Caucasian, African American, and Hispanic) experienced equivalent rates of symptom 
reduction” when taking into account therapist effects which were small, but statistically 
significant.  
Few studies have emerged that specifically consider how veterans of the GWoT respond 
to CPT and PE.  One specific study by Chard and colleagues did report that OEF/OIF veterans 
were more responsive to trauma-focused therapy than were Vietnam Veterans (Chard, Schumm, 
Owens, & Cottingham, 2010).  Further research is needed to aid in pinpointing what factors such 
as age, type of trauma exposure, or other possible contextual variables may have contributed to 
this finding.   
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A final common issue with patients who start CPT or PE is that a significant number drop 
out of therapy before completion.  A number of studies have begun to look at who drops out of 
therapy, when they drop out, and what changes in symptoms or clinical outcomes they were able 
to achieve by the time of termination.  While the current study will not seek to specifically 
explore this special population of early terminators, the statistics regarding the high rate of 
dropouts from trauma focused interventions including CPT and PE are problematic and could be 
addressed in follow-up studies and with further research.  
The current study was completed through the use of a retrospective chart review.  The 
participants included GWoT veterans from OEF/OIF/OND whose service entry dates were 
between September 11, 2001 and September 11, 2015 inclusive.  The 140 veterans included in 
the study represented a diverse sample of servicemembers who had participated in either CPT or 
PE from VA facilities located throughout the U.S.  Veterans included in the study could not be in 
other concurrent modalities of therapy for other mental health diagnoses and this must have been 
the first time they had engaged in a trauma-focused therapy.  The veterans must have met 
diagnostic criteria aligning with the polytrauma clinical triad and must have completed at least 
two of each of the following measures: PCL, BAI, BDI-II, AUDIT-C, and pain scale score.  One 
administration of each measure must have been completed within 90 days of the first session of 
either CPT or PE and a second administration of each must of have been completed within 90 
days of the final session of treatment.    Because the researcher was specifically interested in 
predicting clinical outcomes, changes from pre-to-post treatment were measured using changes 
in scores on each of the measures.  Statistical procedures used to analyze the data included 
descriptive statistics and multiple two-way RM-ANOVAs and RM-MANOVA.  To date, no 
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other known studies have explored clinical outcomes of OEF/OIF/OND veterans with the PCT 
who have completed CPT or PE.  
The next chapter offers a more in depth review of PCT, PTSD, depression, anxiety, 
substance use, and pain in OEF/OIF/OND veterans.  Diagnostic criteria for these mental health 
disorders will be outlined and the two treatments included in this study, CPT and PE will also be 
reviewed in greater detail.   This expansive amount of information will validate the necessity of 
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Chapter II 
Review of the Literature 
This literature review will include an exploration of polytrauma, PTSD, TBI, depression, 
anxiety, pain, and related issues in veteran populations.  A brief history and diagnostic criteria of 
each symptom will be included.  Additional information regarding epidemiology, prevalence, 
common comorbidities, and clinical significance will be detailed as well.  Also included in this 
chapter will be two evidence based treatments for PTSD, cognitive processing therapy and 
prolonged exposure.  The majority of the studies referenced will be from studies conducted with 
veterans although some studies may include different populations.  There will be a short review 
of what is known about individual patient factors such as race/ethnicity, age, and gender and how 
these variables relate to specific PTSD treatment outcomes.  Finally, some limitations of the 
current literature will be noted and a brief description of the current study will follow.  
Polytrauma in OEF/OIF/OND Veterans 
The term “polytrauma” refers to having multiple physical and/or psychological injuries 
co-occurring simultaneously (Otis, et al., 2011).  One of the most common combinations of 
injuries in VA settings is PTSD, TBI, and chronic pain.  This specific combination of diagnoses 
is referred to as the polytrauma clinical triad (PCT).  Current research recommends that a team 
approach is carried out by specialists in their respective fields to treat clients with PCT (Sayer, 
Rettmann, Carlson, Bernardy, Sigford, Hamblen, & Friedman, 2009).  Given the evolving nature 
of war as well as other military involvements, veterans who have served during the wars in Iraq 
and Afghanistan have distinctly different injuries than those who served in previous eras.  TBI’s 
and other concussive disorders have become a hallmark injury associated with combat 
deployments over the past 15 years (Mott, Mondragon, Hundt, Beason-Smith, Grady, & Teng, 
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2014).  Not surprisingly, the increase in TBI’s is also positively correlated with co-morbid PTSD 
and/or chronic pain in veteran populations (Elder, 2015).   
 The exploration of the prevalence rate of the polytrauma clinical triad in OIF/OEF/OND 
veterans is still in its infancy stage.  Several teams of researchers have published initial data 
based mainly on chart review information.  Lew and colleagues (2009) reviewed the medical 
records of 340 OIF/OEF veterans seen at a VA Polytrauma Network Site and reported 
prevalence rates for chronic pain, PTSD, and persistent postconcussive syndrome (PPCS) to be 
present in 81.5%, 68.2%, and 66.8% of that sample respectively (Lew, Otis, Tun, Kerns, Clark, 
& Cifu, 2009).  42.1% of Lew et al.’s (2009) sample reported simultaneously co-occurring 
PTSD, chronic pain, and PPCS.   
A more recent study by Cifu and colleagues (2013) reviewed the medical records of 
OEF/OIF veterans who received inpatient or outpatient care from the VA between 2009 and 
2011 (Cifu, Taylor, Carne, Bidelspach, Sayer, Scholten, & Campbell, 2013).  The researchers 
used International Classification of Diseases- 9th Revision- Clinical Modification codes to 
determine which patients had been diagnosed with TBI, PTSD, and/or pain.  The number of 
veterans who were included as having received services during fiscal years 2009-2011 was 
613,391.  Approximately half (48.2%) reported no history of TBI, pain, or PTSD, meaning that 
the majority of veterans (51.8%) did have a history of TBI, pain, or PTSD. 6%, or 36,804 
veterans had co-occurring TBI, pain, and PTSD diagnosed between 2009-2011.  In other words, 
approximately 12,800 new cases of polytrauma (PTSD, brain injury, and pain) were diagnosed 
each year.  One important limitation that both Lew et al. 2009 and Cifu et al. 2013 highlighted is 
that these data only represent information about veterans who sought services at VA facilities 
and not those who sought treatment elsewhere or did not seek treatment at all.   
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History and Definition of PTSD 
PTSD was first added to the Diagnostic and Statistical Manual of Mental Disorders-Third 
Edition (DSM-III) in 1980 (Friedman, 2015).  One of the key elements for PTSD originally was 
that the individual had to have experienced an exceptionally disastrous stressor such as war, 
torture, rape, a natural disaster, or have been involved in an accident (Kessler, Chiu, Demler, 
Merikangas, & Walters, 2005).  Distress from experiencing “normal” stressors like divorce, 
losing a job, or illness were previously categorized under adjustment disorders.  After much 
more additional research and debate, the criteria for PTSD in the current DSM-5 is quite 
different than it was originally.  There are now 8 sets of criteria that must be evaluated when 
assessing for PTSD (American Psychiatric Association, 2013).  Briefly, the 8 criteria are: (a) 
person has been exposed to a catastrophic event directly or indirectly; (b) having intrusive 
thoughts or memories; (c) avoidance or attempts to reduce exposure to stimuli that provoke 
memories of the trauma; (d) negative cognitions and mood disruptions or constrictions including 
dissociative states; (e) alterations in arousal or reactivity such as panic attacks or aggression; (f) 
symptoms persist for at least one month; (g) the person feels significant functional impairment; 
and (h) the symptoms are not due to medication, substance use, or other illness.   
Arriving at the diagnostic criteria outlined above was not a short or simple process. There 
seemed to be a surge in literature noting the experiences of soldiers who had experienced or 
witnessed the horrors of World War I.  Typically, these individuals were treated by medical 
doctors who were trained to treat physical injuries and had never before seen firsthand the 
devastating effects of war on mental health.  “Shell shock” was the term first coined by a British 
military psychologist, Meyers (1915).  Like the WWI physicians, Meyers believed that shell 
shock was the result of injuries, including internal injuries that were not visible, that caused 
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soldiers to report symptoms such as nightmares, delusions, and heightened startle reflexes.  For 
several decades, soldiers that suffered from these symptoms were thought to have been lying or 
deceitful, cowardly, and unfit for duty. 
Relatively few advancements towards understanding the nature of what we now call 
PTSD were made until the World War II (WWII) era.  Although it may seem insignificant, shell 
shock became known as “combat fatigue” or “combat stress” around this time which marked a 
change towards recognizing the roll that combat played in the development of symptoms.  The 
U.S. military began to develop methods and tools to psychologically screen individuals as a way 
to determine whether or not servicemembers were psychologically fit to continue duty (Lasiuk & 
Hegadoren, 2006a).  One unfortunate outcome of this practice was a strong negative stigma that 
became associated with seeking mental health treatment for servicemembers.  While this 
problem continues today, the DoD and VA healthcare systems are actively working towards 
reducing the stigma around mental health.   
Presently, PTSD is classified as a trauma and stressor-related disorder in the DSM-5. To 
be diagnosed, an individual must meet the 8 criteria for PTSD.  Criterion A is that a person must 
have been exposed to actual or threatened death, serious injury, or sexual violence.  A person 
may meet this criteria if they have directly experienced the traumatic event, witnessed in person 
the traumatic event happen to another person, learned of an especially violent or traumatic event 
happening to a family member or close friend, or be continually exposed to traumatic events 
through experiences related to work (i.e. first responders, police officers, etc.).   Criterion B is 
that one or more of the following must occur after the traumatic event: intrusive memories, 
distressing dreams related to the event, dissociative reactions, intense or prolonged psychological 
distress, or marked physiological reactions to cues that are associated with the traumatic event.  
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Criterion C involves experiencing persistent avoidance of stimuli associated with the traumatic 
event.  Criterion D is having negative cognitions or mood which could include symptoms such as 
the inability to remember important aspects of the traumatic event, feeling detached from others, 
or the inability to experience positive emotions.  Criterion E is changes in arousal and reactivity 
such as hypervigilance, irritability, being easily startled, having difficulty concentrating, or sleep 
disturbances.  The criterion noted in B-E must have occurred for at least 1 month and cause 
clinically significant distress or impairment in social, occupational, or other important areas of 
daily life activities.  And these symptoms must not be attributable to other factors such as 
substance use or another medical condition.   
In recent decades, research has uncovered some findings about risk and prognostic 
factors for PTSD.  Some pre-traumatic factors that increase an individual’s risk for developing 
PTSD during their lifetime include having emotional problems before the age of 6 years, or 
having another mental health disorder such as panic disorder, depressive disorder, or obsessive-
compulsive disorder.  Many of these disorders impact similar brain regions associated with 
PTSD.  People from lower socioeconomic backgrounds with lower education, and those who 
have a history of previous exposure to trauma are at increased risk for PTSD.  Family 
dysfunction (especially during childhood), culture, lower intelligence, minority status, family 
psychiatric history, and poor social support are associated with increased likelihood and poorer 
outcomes for those who do later develop PTSD.  Females, or those who identify their gender to 
be female have higher prevalence rates of PTSD.  A few current studies are exploring if there are 
certain genotypes or other information contained in DNA that may serve as protective factors or 
increase risk for PTSD.  The type and severity of trauma experienced greatly influences if or 
what PTSD symptoms occur afterwards. Cognitions such as thoughts or appraisals, coping 
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strategies, behaviors, and social support are important factors that may moderate adverse 
outcomes after trauma. 
One crucial research project about the link between early life or pre-PTSD factors is the 
CDC-Kaiser Permanente Adverse Childhood Experiences (ACE) Study.   The ACE Study 
(commonly referred to as ACEs) is foundational in its size and scope of investigating the long-
term impacts of childhood abuse and neglect on health and well-being later in life.  The study 
began in 1995 and over 17,000 individuals completed surveys which asked questions about their 
childhood experiences and current health and behavior.  The researchers are continuing to update 
the medical status of the original and new study participants with an eye on morbidity and 
mortality related data.  
The ACE study asked questions about the prevalence of three types of abuse; emotional, 
physical, and sexual.  It also asked about household challenges such as substance use, violence, 
mental illness, access to basic needs including food and clean clothes, parental separation or 
divorce, and incarceration.  Emotional and physical neglect were also inquired about.  Total 
scores were out of 10 and scores of 4 or more indicate significant likelihood of some of the 
following developing throughout the lifespan: alcohol or illicit drug abuse, chronic obstructive 
pulmonary disease (COPD), depression, fetal death, heart disease, liver disease, poor work 
performance (loss of jobs and absences), poverty, intimate partner violence, sexually transmitted 
diseases, suicide attempts, smoking at an earlier age, lung disease, unintended pregnancies,  and 
low academic achievement.  A clear progression of such issues was noted beginning with 
adverse childhood events leading to disrupted neurodevelopment, impairments in social, 
emotional, and cognitive abilities.  Once these impairments have occurred the frequency and 
severity of health-risk behaviors increased resulting is disease, disability, and significant social 
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problems.  Finally, those with higher ACE scores were found to die earlier than those who had 
endorsed fewer than four adverse childhood events or conditions. Higher scores are associated 
with what clinicians and researchers call chronic complex PTSD meaning traumatic stress 
occurred over a long period of time and it is common that the individual has experienced 
multiple types of traumas.  In the context of this study, veterans may have been pre-exposed to 
adverse childhood evens such as physical or sexual trauma and then later exposed to further 
trauma including combat or military sexual trauma.   
To recap, typical symptoms of PTSD include an experience of a traumatic event, 
intrusive symptoms, distress, avoidance, negative impacts on mood and relationships, 
hypervigilance, sleep disturbances, and difficulty with attention, memory, or concentration 
(Kessler et al., 2005; Shiromani, Rauch, & Pitman, 2009).  Dissociative symptoms such as 
depersonalization or derealization may also occur.  It is important to note that it is possible for 
delayed onset of symptoms to occur meaning that some people reports only a few of the criteria 
for PTSD immediately after the trauma and then months or years later experience enough 
symptoms to meet a full diagnosis (American Psychiatric Association, 2013).  
In the U.S., the estimated lifetime prevalence rate of PTSD is 8.7%, but higher in certain 
subpopulations.  The presentation of PTSD symptoms may vary based on an individual’s unique 
interactions between their personal history, multicultural diversity traits, and other co-morbid 
conditions such as TBI and chronic pain.  With a focus on current veteran populations, Magruder 
and Yeager’s (2009) study that used a meta-analysis approach found that the prevalence of PTSD 
among Persian Gulf War veterans was reported to be between 1.9 and 24 percent.  They also 
found that in OEF-OIF veterans, 4.7-19.9 percent acknowledged symptoms that met criteria for 
PTSD.  It is important to note that this study found a wide range of possible PTSD prevalence 
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rates which is likely due to that fact that most of the studies included measured PTSD differently, 
collected data from veterans at different time points, and used varying sampling and statistical 
methods.  Interestingly, Sundin et al. (2010) reported that the prevalence of PTSD prevalence 
was more common or higher if studies used anonymous surveys to collect data and that the 
severity of PTSD symptoms increased in months after returning from a deployment meaning that 
some individuals showed delayed onset.  Of importance to the current study is the prevalence 
rate of PTSD among veterans who seek treatment within the VA healthcare system.  Seal et al. 
(2009) is one of the more recent studies that found an estimated prevalence rate of PTSD within 
VA settings for veterans to be around 22 percent.  With approximately 1 in 5 veterans endorsing 
or meeting criteria for a PTSD diagnosis, there is a clear need for continued research, prevention 
strategies, and improved treatments for PTSD in veteran populations. 
PTSD and the Brain 
Although not necessary to make a PTSD diagnosis, neurobiological research has 
pinpointed changes in the central and autonomic nervous systems of people who have 
experienced traumatic stress (Friedman, 2015).  Central and automated nervous system changes 
manifest often as heightened startle reflexes and changes in sleep.  Brain imaging technology has 
also shown that PTSD is associated with reduced volume of the hippocampus and anterior 
cingulate (Friedman, 2015; Shiromani et al., 2009).  Additionally, functional magnetic resonance 
imaging (fMRI) demonstrates that traumatic stress often is linked with increased amygdala 
activity while simultaneously decreasing activity in the prefrontal cortex and hippocampus 
(Shiromani et al., 2009).  These brain changes are likely part of the underlying mechanisms that 
affect post-trauma changes in thoughts and behaviors and could have further implications when 
TBI and/or chronic pain co-occur with PTSD.   
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Many researchers have attempted to examine the structural changes in the brain as they 
relate to PTSD.  Most agree that the amygdala, medial prefrontal cortex, and hippocampus 
(including their subcomponents) are the most salient brain parts to understanding PTSD.  Shin 
and colleagues (2006) used neuroimaging research to reveal heightened amygdala responsivity 
when PTSD-states were induced (Shin, Rauch, & Pitman, 2006).  Increased amygdala activation 
also occurred when individuals were attempting to process trauma-unrelated affective 
information such as viewing non-threatening facial expressions.  The volume of the medial 
prefrontal cortex in PTSD clients is smaller than those without PTSD and it is also less 
responsive when trauma-related states were induced.  The final brain area that Shin et al. 2006 
studied was the hippocampus.  They found that the volume of the hippocampus in PTSD clients 
was smaller than non-PTSD clients.  The hippocampus was also demonstrating less neuronal 
activity.  These findings may suggest that caution should be used when selecting the most 
appropriate type of therapy for PTSD if a client also has a known history of TBI and reports 
chronic pain.  
Similar to Shin et al.’s (2006) work, Stein and colleagues also studied whether or not 
trauma alters neuroanatomy noting that “it is generally widely accept that stress-induced 
elevations of glucocorticoids augment the extracellular accumulation of excitatory amino acids 
such as glutamate” which results in damage to the hippocampus (Stein, Hanna, Koverola, 
Torchia, & McClarty, 1997). This damage is evidenced by reduced cell sprouting and increased 
neuronal cell death in the hippocampus as well as function impairments related to learning and 
memory.  In other words, chronic distress increases hormones that suppress the immune system 
leading to increased vulnerability to illnesses like ulcers, high cholesterol and diabetes.  Chronic 
distress also makes it harder for the brain to process and store memories such as those from 
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trauma.  Unprocessed or unfiled memories from trauma resurface as flashbacks or intrusive 
thoughts.  Shin et al. (2006) reviewed several studies including Bremner’s work showing that 
combat veterans with PTSD had reduced right-sided hippocampal volume which were associated 
with short term verbal memory deficits (Bremner, 2006; Bremner, Elzinga, Schmahl, & 
Vermetten, 2008).  These findings are of particular importance for practitioners to consider when 
using a trauma-focused approach to therapy such as CPT or PE with clients who may have 
impairments in learning and memory brain structures.  Brain structures involved in learning and 
memory are likely utilized during processing traumatic memories, thoughts, and emotions.    
Finally, neuroanatomical topics covered in depth by Shin et al. (2006) included the 
components of the HPA axis.  The hippocampus in PTSD is reduced in volume and activity 
which alters the ability to respond to stress and inhibits extinction.  The amygdala increases in 
activity and size which increases hypervigilance, but decreases the ability to discriminate threats 
and non-threats. The cortex shows reduced prefrontal volume associated with the dysregulation 
of executive functions.  The anterior cingulate shrinks in volume which impairs the extinction of 
fear responses, and there seems to be decreased medial prefrontal activation, but it is unclear 
what that specifically effects at this time. Consistent with the findings of other research 
presented, this study solidifies the importance of practitioners understanding the nature of how 
PCT impacts which therapies for PTSD might work best with each individual client and that 
psychotherapy in conjunction with pharmacotherapy may be most efficacious in real-world 
settings.  
Seal and colleagues found that PTSD was the single most common mental health 
diagnosis in their study of over 100,000 OEF/OIF veterans (Seal, Bertenthal, Miner, Sen, & 
Marmar, 2007).  Veterans with PTSD are at higher risk for other diagnoses such as depression, 
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chronic pain, substance use disorders, and other medical conditions (Morasco, Lovejoy, Lu, 
Turk, Lewis, & Dobscha, 2013). Additionally, patients who are diagnosed with PTSD not only 
are more likely to have chronic pain, but the severity of their pain and related impairments is 
higher than those without PTSD (Geisser, Roth, Bachman, & Eckert, 1996).  One of the 
contributing factors for this finding is that those with PTSD, depression, and chronic pain often 
have significantly higher levels of maladaptive thought patterns, poor coping strategies, and 
unsupportive biopsychosocial environments (Alschuler & Otis, 2012).  There is a large amount 
of overlap in symptoms relevant to PTSD, chronic pain, and brain injuries.  Interventions 
targeted at reducing the symptoms related to one diagnoses such as PTSD may improve other 
conditions.  This idea will continue to be developed throughout this paper. 
Comorbidities of PTSD 
 It is often the case that people who have PTSD also have other comorbid diagnoses.  In a 
study done by Kessler et al. (1995), as many as 90 percent of people in the general population 
who had been diagnosed with PTSD also met diagnostic criteria for at least one other mental 
health disorder during their lifetime.  The most commonly reported co-occurring disorders were 
major depression, substance abuse including alcohol and/or drug abuse or dependence, and 
anxiety disorders. Magruder et al. (2005) explored this issue of comorbid disorders with PTSD in 
the VA system and uncovered similar findings.  The most common diagnoses in addition to 
PTSD in their VA sample were major depression, alcohol and/or drug abuse or dependence, and 
anxiety disorders.  This information highlights how PTSD can be a chronic and long term 
disorder that is often accompanied by other serious symptoms and diagnoses that may greatly 
impede on the quality of life experienced by those impacted.  
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 To expand on how PTSD has been found to decrease quality of life, Schnurr et al. (2009) 
reported that OEF/OIF veterans who had been diagnosed with PTSD were much more likely than 
those without the diagnoses to be unemployed, homeless, report issues with interpersonal 
relationships, and be divorced.  It is thought that veterans with PTSD may attempt to alleviate the 
psychological distress of PTSD and the associated symptoms through increased alcohol and 
substance use.  Many studies have looked at drug and alcohol abuse and dependence in military 
populations.  A common finding has been that around 25%-30% of active duty service members 
endorse hazardous drinking (Kessler et al., 1995; Hodge et al. 2007).  Scott et al. (2013) also 
found that younger veterans and those who identified as male were at greater risk for alcohol 
dependence or risky drinking.  This trend is alarming in light of other studies who have 
associated alcohol and substance use in veterans who have PTSD with higher rates of violent 
behaviors including domestic violence and higher rates of suicidal ideation (Guerra & Calhous, 
2011; Zatzick et al. 1997).   
Traumatic Brain Injury 
Traumatic brain injuries present in a multitude of ways.  There is no one clear definition 
of what a TBI is, but there is agreement that brain injuries occur on a spectrum of severity.  The 
Department of Defense’s 2007 definition from their Mild Traumatic Brain Injury Pocket Guide 
App offers a broad description of TBI’s as being “traumatically induced structural injuries and/or 
physiological disruption of brain function as a result of an external force.”  External forces are 
understood to be things like being struck in the head by an external object, the head striking an 
object, brain accelerating or decelerating (whiplash) without direct external contact from an 
object, a foreign body penetrating the brain, or from forces generated by events such as blasts or 
explosions.  The leading causes of TBI’s in military populations include blasts, motor vehicle 
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accidents, fragments or shrapnel, and falls (Bahraini et al., 2014). To be considered a TBI, one of 
the following must occur: period of loss or decrease in level of consciousness (LOC); loss of 
memory for events before, during or after injury (post-traumatic amnesia); any alteration in 
mental state at the time of injury such as confusion or disorientation; neurological deficits such 
as weakness, loss of balance, changes in vision or other senses; or intracranial lesions.  It is 
evident why differentiating between where symptoms that could overlap PTSD, TBI, or chronic 
pain pose a problem for those diagnosing and treating clients. 
TBI is a common injury sustained in both civilian and military populations.  
Approximately 10 million new TBI’s are diagnosed worldwide each year (Otis et al., 2011).  Due 
to factors like lack of access to care and unreported cases, researchers estimate that the true 
number of new TBI’s each year is closer to 42 million cases (Otis et al, 2011).  TBI’s have 
become a hallmark injury of veterans who have served in the military over the past few decades.  
This contributes to a significant portion of combat related disability and health care costs 
reported by the VA.   
Furthermore, TBI’s sustained during military service are often associated with PTSD so 
much so that distinguishing symptoms of TBI from PTSD have become increasingly difficult 
(Sayer et al, 2009).  Over one-third of Iraq veterans with concussive syndromes also have PTSD 
or depression (Sayer et al, 2009).  Elder (2015) by states that there is “limited/suggestive 
evidence that most of the shared symptoms [of TBI and PTSD] are accounted for by PTSD and 
not a direct result of TBI alone.” Brenner and colleagues (2013) found that approximately 45% 
of Veterans who sought treatment from VA’s had a likely history of at least one incident of TBI 
(Brenner, Homaifar, Olson-Madden, Nagamoto, Huggins, Schneider,…Corrigan, 2013).   
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Recent postmortem human studies have documented the impact of long-term 
inflammation associated with the occurrence of TBI up to 17 years after the injury occurred 
which has led to researchers believing that this may be a key factor in the development of mild 
cognitive impairments and dementias (Elder, 2015).  In fact, multiple studies have found a two-
fold increase in the risk of developing dementia in Veterans with PTSD (Elder, 2015).  These 
findings suggest that developing and integrating mental health treatment approaches to address 
PTSD symptoms in clients who have a likely history of TBI may be of increasing importance in 
future Veteran populations as a potential way to disrupt the projection of conditions such as early 
onset dementias.  
Chronic Pain 
Literature on chronic pain offers an array of definitions for what chronic pain is. The 
most commonly used definition is from the International Association for the Study of Pain, 
which defines chronic pain as any pain that lasts beyond the “normal” healing phase of an injury 
(Apkarian, Baliki, & Geha, 2009). What constitutes a normal healing phase seems to be 
subjective and thus many practitioners use this idea loosely as one guideline to aid in 
determining if the pain is chronic or not given the context of each individual client’s presenting 
concerns.  Other researchers have defined chronic pain as pain that persists for at least 3 months 
and it originally accompanied a disease or injury that has healed (Clark, Bair, & Buckenmaier, 
2007; Gironda, Clark, Massengale, & Walker, 2006). In other words, chronic pain could be 
defined as pain that continues to occur persistently for at least 3 months after an injury is 
considered to be healed.  
Lew et al. (2009) discuss the significance of chronic pain in veteran populations, 
particularly those with combat related injuries.  They report that the most common locations of 
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pain in veterans are the head, back, legs, and shoulders.  Because chronic pain in veterans is 
often associated with another injury, disease, or mental health diagnosis, it often impacts 
additional areas of functioning which may result in disability. Some commonly reported areas of 
functional impairment in the literature include psychological distress, family or interpersonal 
discord, and vocational issues (Clark et al. 2007; Gironda et al. 2006; Lew et al 2009).  
 In 2011, the National Institute of Health reported that chronic pain can occur for a variety 
of reasons, such as: injury, illness, or other health problems. Since Veterans are a population that 
experiences a high rate of injury, it is logical that they also experience high volumes of chronic 
pain cases.  In addition to pain, there are other symptoms associated with chronic pain, such as: 
fatigue, sleep disturbance, decreased appetite, and loss of mobility.  These issues, when 
combined with TBI and PTSD to form the PCT, present challenges to addressing client concerns 
in any clinical setting.  It is plausible that the longer someone has experienced chronic pain that 
different or more structures of the brain may be impacted as well. Finally, these findings speak to 
the overall point that one single area of the brain does not have one single function. In fact, 
where disorders such as chronic pain are concerned, many areas of the brain can be impacted at 
one time and can be nearly impossible to distinguish from the symptoms of other co-occurring 
disorders.  
 Honda, Maruta, and Takahashi (2007) examined blood flow variations in the brains of 
individuals with chronic pain to those who did not have chronic pain. The researchers used a 
device called a single-proton emission computed tomography (SPECT), which shows how blood 
is flowing to various organs in the body (Mayo Clinic, 2014). The study included 15 subjects 
who had been experiencing chronic pain from 6 months to 11 years (Honda et al., 2007). There 
were 7 males and 8 females ranging in age from 20-76 years old (average age 49.1 years).  The 
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pain locations ranged from back, neck, knee, and other areas. Subjects in the study did not have 
any psychological disorders and were only taking medications specific to pain. Study 
participants were placed on bed rest and their brains were examined using the SPECT. The 
images from each scan were compared to another brain image of someone who was the same age 
but not diagnosed with a chronic pain disorder.  
Images from the study were reviewed and showed reduced blood flow in 4 different areas 
of the brain: dorsolateral prefrontal area, medial prefrontal cortex, anterior cingulate gyrus, and 
orbital frontal cortex (Honda et al., 2007). The medial prefrontal cortex had reduced blood flow 
on both sides of the brain, while the other 3 brain areas had reduced flow primarily on the right 
side of the brain. The dorsolateral prefrontal area and medial prefrontal cortex had the most 
significant blood flow reduction. The reduced blood flow in these areas of the brain can have 
significant impacts on an individual especially in the area of mood, muscle control and 
movement, and cognition (Honda et al., 2007).  A reduction in blood flow to the prefrontal area 
of the brain has been linked to depression. Along these lines, the reduced blood flow in the 
cingulate gyrus can impact movement and muscle control. Changes in mood, especially 
depression, and general cognition, can be particularly difficult to attribute to a single cause in 
PCT clients.  In other words, it is often unclear if changes in symptoms or functioning such as 
mood and cognition are a result of PTSD, TBI, or chronic pain which makes choosing how to 
treat these issues especially cumbersome even when a team of specialists with access to top of 
the line resources is available.  
Depression 
 Depression is one common symptom that occurs after an individual experiences trauma.  
Most describe depression as a prolonged experience of sadness or low mood with a loss of 
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interest and often includes changes in appetite, sleep, energy, thinking patterns including 
memory and attention, and disinterest in usual activities.  Approximately 10% of Americans over 
the age of 18 are diagnosed with some type of depression each year (Kessler, Chiu, Demler, 
Merikangas, & Walters 2005).  It is estimated that after a traumatic event, about 1 in 4 adults 
develop depression.  For example, after the Oklahoma City bombing 23% of those who 
personally experienced the event met criteria for a depression related diagnoses separate from a 
PTSD diagnosis (North, Nixon, Shariat, Mallonee, McMillen, Spitznagel, & Smith 1999).  PTSD 
and depression often co-occur at similar frequencies following a traumatic event.  Individuals 
with PTSD are 3 to 5 times more likely to have depression than those without PTSD (Kessler, 
Sonnega, Bromet, Hughes, & Nelson 1995).  According to the VA, as of December 2014, of the 
OEF/OIF/OND veterans that have accessed care through the VA, approximately 45% have met 
criteria for a provisional mental health diagnosis of depression.  This is the second most common 
provisional diagnoses with PTSD being the most common.  
Depression is unique from PTSD in that for some people it may seem to occur with no 
specific trigger whereas PTSD requires there to be a traumatic event first.  It is possible to 
experience trauma and not develop PTSD, but develop depression instead.  It is often difficult to 
tease apart whether symptoms are a function of PTSD or depression since there are often many 
that overlap between the diagnoses.  This is one of the reasons why it is important for clinicians 
to understand both diagnoses and be able to treat both in effective and efficient manners.  
Decades of research is available that goes into great depths to detail treatment options for 
depression.  There are currently many different types of medications that are recommended for 
the treatment of depression as well as PTSD.  Selective serotonin reuptake inhibitors (SSRIs) are 
an example of a class of medications that have been shown to be successful in reducing 
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depressive symptoms.  A few commonly prescribed SSRIs include Zoloft, Lexapro, Paxil, and 
Prozac.  SSRIs are intended to ease depressive symptoms.  Antidepressants are another type of 
medication used to prevent depression and elevate mood.  Some examples of antidepressant 
prescription medications include Wellbutrin, Effexor, and Cymbalta.  Other natural remedies 
such as St. John’s Wart, 5-HTP, and Omega-3 Fatty Acids are available as over-the-counter 
treatments for depression, but they are not approved or regulated by the Food and Drug 
Administration (FDA) and more research is needed on the use of these substances.  
While some people prefer or respond well to medication alone, others are interested in 
therapy or a combination of medication plus therapy. Cognitive behavioral therapy (CBT) is an 
evidence based treatment backed by strong research findings for the treatment of depression.  
CBT helps patients to create more adaptive thinking patterns and often leads to behavioral 
activation changes as well.  CBT has also been used effectively with PTSD patients and is 
similar to cognitive processing therapy (CPT) that is an evidence based psychotherapy for PTSD.  
Anxiety 
 Until the DSM-V, Anxiety was included in the same section as PTSD.  Not surprisingly, 
both disorders share many overlapping traits.  In healthy individuals, some level of anxiety is 
beneficial because it is what alerts us to potential threats in the world around us and then through 
activating the nervous system informs us whether to go into fight or flight mode.  Specific brain 
parts including the thalamus, visual cortex, and amygdala work together during periods of stress 
or anxiety. After the first rush of an initial detection of a potential threat, other parts of the brain 
also begin to increase in activity.  Some of these regions include the cingulate gyrus (avoidance 
of pain), orbitofrontal cortex (reward and emotion), thalamus (sensory and motor signals), 
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caudate nucleus (movement, learning, and memory) and nucleus accumbens (reward and 
addiction) (Lambert & Kinsley, 2011).   
In cases where PTSD and anxiety co-occur, high levels of anxiety are often noticed as 
avoidance behaviors and hyperarousal.  Individuals may tend towards self-medicating to numb 
or reduce the distress caused by anxiety.  It is not uncommon for those who suffer from anxiety 
to have issues with drug or alcohol abuse as they may be more prone to develop dependence if 
drugs or alcohol are used at times when they feel particularly anxious or distressed and the brain 
regions associated with learning, reward, and addiction are more active than other parts such as 
the prefrontal cortex that would be involved in rational decision making.   
There are several types of anxiety disorders including Generalized Anxiety Disorder 
(GAD), phobias, and panic.  The focus for this literature review will be geared towards GAD as 
it is most often the form of anxiety disorder that co-occurs with PTSD.  GAD includes 6 
diagnostic criteria: A) Obsessive anxiety and worry that occurs more days than not for at least 6 
months about various events; B) The individual finds it difficult to control the worry; C) 3 or 
more of the following must occur more days than note for the past 6 months: restlessness/feeling 
on edge, fatigue, difficulty concentrating/memory issues, irritability, muscle tension, sleep 
disturbances; D) Symptoms cause clinically significant distress or impairment; E) The 
disturbances are not due to other substances or medical condition; F) The symptoms are not 
better explained by another mental disorder. Additionally, many people who experience this type 
of anxiety report somatic complaints and hyperarousal.   
The prevalence rates for GAD in the general adult population in the U.S. are around 2.9% 
annually and 4-7% lifetime prevalence. Females are about twice as likely as males to develop an 
anxiety disorder.  Caucasians of European decent report higher rates of GAD than non-
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Europeans.  The median age of onset for GAD is 30 years, but there is a wide variance in age of 
onset and the clinical expression of symptoms may vary greatly over time.   
Some risk factors that have been correlated with GAD include behavioral inhibition, 
neuroticism, and avoidance.  People who have faced adversities including low SES are at 
increased risk.  It has been estimated that about one-third of GAD cases have genetic links that 
overlap with other issues such as neuroticism, and other anxiety and mood disorders. It is also 
important to note that many cultures report variations in the expression of anxiety.  Of potential 
importance to this study, females with anxiety tend to also report unipolar depression, but males 
with anxiety tend to report more issues with substance use.  
Alcohol and Substance Use  
 The results of several studies have found that around 40% of OEF/OIF veterans who seek 
services within the VA healthcare system screen positive for alcohol misuse which includes a 
range of severity from risky drinking to dependence.  Younger servicemembers report heavier 
drinking and higher rates of alcohol dependence than older veterans.  This finding is 
compounded by complicating issues including higher rates of history of traumatic brain injury 
that are found in veterans from the OEF/OIF era compared to veterans from previous eras. The 
misuse of alcohol has many negative impacts for those recovering from brain and/or bodily 
injury including slowed recovery from PTSD, financial and legal issues, increases in incidents of 
violence, oral cancers, diabetes, damage to brain functioning, and even early death.   
Given the unique nature and hallmark injuries of war sustained by current era veterans, 
increasing rates of incidents of substance abuse such as the misuse of prescription opioids has 
become an alarming trend.  Picket et al. (2015) reported that since 2008 there was a 76% 
increase in veterans with PTSD that reported a co-morbid substance use disorder. Picket et al. 
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(2015) also found that there was a 425% increase in reported anxiety disorders for active duty 
soldiers from 2000 to 2012 and that concurrently, 5 to16 % of veterans were reporting levels of 
depression at or above diagnosable criteria.  Of further concern was that about 7% of respondents 
reported that they had seriously considered suicide after joining the military.  
Not all substances can be discussed within the limits of this paper, but alcohol is one of 
the most commonly used substance by veterans.  Cigarettes or other tobacco products are also 
very commonly used, but rarely result in the types of consequences that alcohol or other illicit 
drugs do.  The fact that alcohol is so heavily used by veterans is deserving of attention because 
alcohol is the fourth leading cause of preventable death in the US according to the National 
Highway Traffic Safety Administration.   Furthermore, 31% of driving-related fatalities involve 
impairment by alcohol.  Even worse, alcohol decreases insight and judgement abilities while 
increasing impulsivity and risk-taking behaviors.  This is incredibly problematic when it comes 
to veterans with mental health diagnoses that increase the risk of suicide who drink alcohol and 
have access to firearms.  Studies that have specifically looked at alcohol use among veterans 
consistently find that alcohol use is strongly associated with increased risk of interpersonal 
violence, health complications, and death (Savarese, Suvak, King, & King 2001).   
The US is currently experiencing an opioid epidemic.  The same misuse of prescription 
drugs like opiates has drastically inclined in recent years. Opioids are one of the most addictive 
prescription drugs which are being prescribed at increasing rates to veterans for ailments like 
headaches and chronic pain (Macey, Morasco, Duckart, & Dobscha 2011).  Bohnert, Ilgen, and 
Trafton (2014) found that over an 8 year span between 2001 to 2009, opioid prescriptions for 
veterans in the VA increased from 17% to 24%.  During that same period, the number of pain 
medication prescriptions in total written by military physicians increased by over 400%.  Nearly 
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1 in 5 veterans with a diagnosis of PTSD are prescribed opioids.  About 12% of veterans with 
any mental health diagnosis are prescribed opioids compared to 6.5% of veterans with no mental 
health diagnosis.  The combination of being a veteran with a mental health diagnosis, especially 
PTSD, and being prescribed opiate pain medication is predictive of an increase in likelihood of 
inpatient admissions, use of emergency department services, violence, legal problems, and many 
other consequences.  Use of other types of illicit drugs among veterans is relatively the same as 
their civilian equivalents. About 4% of both populations report illicit drug use within the past 
month (Wagner, Harris, Federman, Dai, Luna, & Humphreys 2007).  Marijuana is the most 
commonly reported type of illegal drug by veterans.  About 3.5% of veterans report current past-
month use of marijuana (Wagner et al. 2007).  
Many veterans with PCT suffer from substance use disorders including the misuse of 
prescription drugs.  The complex nature of the combination of PTSD and substance use can be 
very difficult to treat for medical and mental health professionals.  Veterans often report using 
substances as a coping mechanism to avoid the reality of dealing directly with symptoms related 
to their PTSD, depression, pain, sleep disorders, and much else. Often, patients have noted that 
they will stop using substances when their other mental health symptoms have been treated first.  
For years, professionals have debated on whether it is best to address substance use or PTSD 
first.  The answer that many have found after years of trial and adjustments is that the solution is 
often neither of those options.   
New interventions like Seeking Safety or interdisciplinary methods have been developed 
which effectively target both substance use and trauma related symptoms at the same time.  
Herman’s 3 stage of recovery from trauma are often used with veterans who have both PTSD 
and substance use.  The first stage focuses on stabilization and safety and often involves a 
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treatment like Seeking Safety and/or dialectical behavior therapy.  The second stage is one of 
recovery and mourning once stabilization has been consistently observed for a reasonable period 
of time.  Evidence based psychotherapies such as eye movement desensitization (EMDR), CPT, 
or PE are used during stage two.  The third stage is reconnecting with the world and engaging in 
meaningful activities once again.  Many patients continue to engage in various forms of therapy 
during this third phase of treatment and often continue to do so periodically throughout their life.  
Evidence Based Therapies for PTSD: CPT and PE 
Cognitive Processing Therapy (CPT).  Cognitive Processing Therapy (CPT) is an 
evidenced-based manualized treatment protocol developed for clients with PTSD and other 
related symptoms following traumatic events.  According to the National Center for PTSD, 
Cognitive Processing Therapy is "one of the most well-researched cognitive approaches, has a 
primary focus on challenging and modifying maladaptive beliefs related to the trauma, but also 
includes a written exposure component and highly structured psychoeducational components" 
(Resick, Galovski, Uhlmansiek, Scher, Clum, & Young, 2008).  It focuses on how the traumatic 
event is interpreted and handled by the affected individual.  This is a highly structured treatment 
that is conducted as a 12 session protocol that can be done in individual sessions or group 
therapy with modifications.   
Background on CPT.   
CPT grew out of the need for better psychological interventions and understanding of the 
experiences of rape victims in the 1970’s.  Interestingly, it was around this time period that the 
act of raping a woman began to be chronicled as a way that males were able to hold on to 
political power.  Susan Brownmiller’s book, Against our Will, is a prime example of this 
enlightenment and led to women coming together to hold “speak outs” through new groups such 
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as the National Organization for Women.  By the end of the 1970’s it had become evident that 
rape culture that used to be rarely spoken about was a much larger and deeper issue than 
previously thought.  The National Institute of Mental Health began to set aside millions of 
dollars in funding to support studies on rape.  The initial studies that later led to the creation of 
CPT were funded by NIMH grants. 
During the early stages of research with rape victims, longitudinal studies were used to 
examine the constructs of fear, depression, and anxiety.  Brief behavioral interventions were used 
as well as stress inoculation training.  Additional studies attempted to use assertiveness training 
as a way to counteract fear responses.  When the DSM-III was published in 1980, rape was 
included in the anxiety disorders category under PTSD, but there were no existing measures of 
PTSD available that made it possible to compare pre-treatment to post-treatment symptom 
differences.  Rape responses continued to be understood within the context of classical 
conditioning where the initial reaction to the trauma of rape resulted in a fear response which 
then led to a second-order response or conditioning that generalized the fear reaction to other 
triggers. Also of importance was the finding that escape and avoidant responses were hallmark 
behaviors associated with PTSD.  During the mid-1980’s, Foa and Kozak introduced the 
emotional processing theory of PTSD that was founded on Lang’s (1977) theory involving fear 
networks that develop based on exposure to a traumatic stimulus that an individual has impactful 
responses to and assigns meaning to.  The pioneering researchers of CPT did not accept the idea 
that PTSD was simply a fear/anxiety disorder.  Instead, they sought to include cognitive theories 
to explain and treat PTSD.  Progress on creating effective and well-researched interventions for 
PTSD was slow for several decades, but began to pick up pace by the 1990’s. 
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Theories that Influenced CPT.  Other important lines of research that influenced the 
development of CPT heavily focused on depression developing from lower levels of positive 
reinforcement, learned helplessness, and constructivist self-development theories of traumatic 
victimization.  Essentially, there was a belief supported by available theories that people actively 
create their own personal realities based on how they think about their experiences or what 
meaning they construct from their life.  The experience of trauma may markedly shift one’s 
beliefs about themselves and the world around them.  When trauma experiences can’t be 
understood by existing schemas, people may either cognitively alter new information to 
assimilate it into their existing beliefs, or new learning occurs and is accommodated for.   
Another unique factor that influenced or led to a different theoretical approach used in 
CPT is the broader range of emotions that are intended to be inclusively addressed in CPT.  
Since PTSD had been classified as an anxiety disorder until the DSM-5 was published in 2013, 
previous treatments for PTSD often focused almost exclusively on anxiety and fear.  CPT aims 
to also address other emotions including guilt, shame, disgust, sadness, and the like.  Several 
studies in the mid 1990’s were finding that PTSD was not as centered around fear as previously 
thought.  This was concluded by findings from studies that noted that not all traumas had equal 
effects in regards to fear.  In fact, most people were able to recover from fear, but their other 
PTSD symptoms persisted that were associated with flashbacks, intrusive memories, nightmares, 
and avoidance.  Fear did seem to be a better predictor of PTSD when the trauma experienced was 
interpersonal such as rape, but not when the trauma was from an impersonal event like a natural 
disaster.  
Biological Model of PTSD and CPT.  Advances in medical technology have had a great 
positive impact on the research and literature available surrounding brain science and PTSD.  
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Some of the most notable findings have come from gaining a greater understanding of the 
biological drivers of PTSD.  Much of the research has centered on the role that the amygdala 
plays in triggering strong emotional responses in emergency situations.  Numerous studies have 
also repeated found that the prefrontal cortex in those individuals diagnosed with PTSD tend to 
show diminished responsivity and are smaller in size. Combined, these findings give light to 
some of the ways in which CPT works to relieve symptoms.  
 The prefrontal cortex, the outer portion of the brain that sits directly behind the forehead, 
is typically the head of making decisions and sending control signals back to the amygdala.  In 
an event where the prefrontal cortex has decided that the individual is in a threatening situation, 
it sends neurotransmitters to other areas of the brain to decrease processes like immune system 
functions or other physiological responses such as digestion.  It effectively directs an increased 
amount of neurotransmitters to regions like the amygdala to trigger emotions necessary in the 
fight or flight response such as fear and anger.  Normally, the prefrontal cortex is able to detect 
when the emergency is over with so that it can signal the amygdala to stop the fight or flight 
response and return to the normal state of parasympathetic functioning.  However, many people 
with PTSD have amygdalas with higher levels of responsivity and at the same time their 
prefrontal cortex shows decreased activity.  In a sense, their brain is stuck in a hypersensitive 
mode where the amygdala is continually telling the body to prepare for fight or flight and the 
prefrontal cortex is unable to send messages to regulate the undesired responses.  The body has 
no way of then detecting when it is safe to return to a calm or more relaxed state.  CPT aims to 
interrupt the cyclical dysfunctional patterns of communication between the prefrontal cortex and 
amygdala.  In a sense, it re-trains the prefrontal cortex through the patient learning how to 
identify cognitive stuck points and respond in a more desirable way.  Additionally, having the 
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patient process thoughts and emotional reactions to memories in a safe environment such as a 
therapy session provides the individual with healing and corrective learning experiences.  
 A 2003 study by Hariri and colleagues found that when participants were asked to use 
words to label objects or to describe what type of danger, natural or artificially created, an image 
was, the use of verbal language activated the prefrontal cortex and simultaneously there was a 
reduction in activation of the amygdala.  This finding led to the specific ingredient of CPT that 
requires the patient to talk about their trauma history rather than have them imagine re-
experiencing the traumatic event in therapy repeatedly. The theory about having clients talk 
about their trauma in CPT ties into cognitive therapy by using language to activate the prefrontal 
cortex, the amygdala should become less reactive allowing for cognitive restructuring of 
thoughts to occur. Additionally, CPT may help patients to build skills related to affect regulation, 
increased cognitive flexibility, and reexamining avoidance of thoughts and behaviors by 
targeting the prefrontal cortex and amygdala. 
Research on CPT.  Although Cognitive Processing Therapy has been modified slightly 
over the past few decades, it has continually been shown to produce effective outcomes.  Several 
versions of CPT exist.  Originally, CPT was 12 structured sessions which included both 
cognitive therapy and a written exposure portion.  The written portion was later called a “written 
account” of a specific traumatic event.  A dismantling study by Resick et al, 2008, reported that 
when CPT was used without including written accounts (CPT-C) it was just as effective as CPT 
that included having patients write written accounts of their trauma. Resick et al, 2008 also noted 
that CPT-C participants had faster rates of improvements and lower dropout rates when 
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Background on Prolonged Exposure.  Prolonged Exposure (PE) was first developed in 
the early 1990’s by Foa, Rothbaum, Riggs, and Murdock (1991) and grew out of Foa and 
Kozak’s Emotional Processing Theory (EPT).  EPT focuses on how people form fear structures 
that allow them to avoid perceived danger or threats.  Initially, PE was used as an intervention 
for rape victims that were seeking mental health services.  The foundation of PE lies within 
behavioral psychology.  Specifically, PE aligns with the beliefs that fear and other similar 
reactions are developed through classical conditioning.  In other words, people form associations 
based on the stimuli that they encountered during times of trauma.  PE goes further to assert that 
these undesired associations that are observed as symptoms of PTSD continue because of 
operant conditioning or negative reinforcement that is often perpetuated by avoidance and 
anxiety.  Prolonged Exposure Therapy (PE) is an evidenced-based, manualized protocol for the 
treatment of PTSD.  At its core, PE’s primary mechanism of change is driven by emotional 
processing via in vivo exposures that occur in sessions by processing memories of traumatic 
events.  Typically, PE is done in about 8 to 15 individual psychotherapy sessions that are 60 to 
90 minutes long (Foa, 2011).   
According to the Center for Deployment Psychology, "PE is based in Emotional 
Processing Theory, which posits that PTSD symptoms arise as a result of cognitive and 
behavioral avoidance of trauma-related thoughts, reminders, activities, and situations." PE helps 
interrupt and reverse this process by "blocking" cognitive and behavioral avoidance, introducing 
corrective information, and facilitating organization and processing of the trauma memory and 
associated thoughts and beliefs (Resick, Nishith, Weaver, Astin, & Feuer, 2002; Marks et al., 
1998). The process of adapting new thought patterns is done through in vivo and imaginal 
exposure.  One of the reasons this therapy may be so effective is the ways in which it 
 
 
- 41 - 
 
incorporates the major areas of the brain that are affected long-term by traumatic stress such as 
the amygdala, hippocampus, and the frontal/prefrontal cortex. 
In in vivo exposures the client repeatedly engages in activities, situations, or behaviors 
that are avoided because of the trauma, but which are not actually dangerous. Over time, in vivo 
exposure lessens disproportionate fear, and other disturbing emotions, and facilitates the 
recognition that the avoided situations are not as dangerous as initially thought, and over time the 
client will find empowerment through learning from new experiences where they can effectively 
cope even when distressed (Foa and Rothbaum, 1998). Imaginal exposure involves repeatedly 
revisiting the traumatic experience in memory through the client imagining the experience while 
describing the event aloud in detail. The narrative is recorded, and the client listens to the 
recording between sessions. Revisiting the event in this way encourages re-processing of the 
trauma memory by activating the thoughts and emotions associated with the trauma in a safe 
environment.  
PE Research.  Many studies over the past two decades have shown that PE significantly 
reduces the symptoms of PTSD, as well as co-morbid symptoms of depression, anger and 
anxiety (Benish, Imel, & Wampold, 2008; Foa, Keane, Friedman, & Cohen, 2009; Ehlers, 
Bisson, Clark, Creamer, Pilling, Richards, …Yule, 2010; Cusack, Jonas, Forneris, Wines, Sonis, 
Middleton, …Gaynes, 2016). Many clients report and demonstrate that they are better able to 
differentiate between genuinely safe and unsafe situations, and experience improvements in their 
activities of daily functioning.  Foa, Hembree, and Rothbaum (2007) noted that nearly all studies 
for more than 2 decades that considered other trauma-related issues such as anxiety, depression, 
anger, and guilt found that PE not only reduces PTSD symptoms, but those issues as well.   
Comparing CPT and PE.   
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There are a few limitations that must be considered when implementing either CPT or PE 
with patients.  Both of these interventions rely on the readiness of the patient to confront or 
approach their trauma-related memories while resisting avoidance behaviors.  Since avoidance is 
often one of the biggest issues faced by those with PTSD, both CPT and PE are plagued by 
higher than desired dropout rates.  It is critical that therapists assist patients by reinforcing that 
rationale for treatment and noting that the benefits of completing therapy outweigh the initial 
discomfort experienced.   
Dropout rates for CPT and PE have varied greatly across studies because different 
researchers have operationally defined what treatment dropout is. The most stringent studies 
(such as Monson et al. 2006) define dropout as failure to complete the full protocol of therapy, 
but others are less restrictive and have defined dropout in terms of needing to have attended a 
certain percentage of sessions such as two-thirds (Jeffreys et al., 2014).  Dropout rates for CPT 
tend to range between 20-32% (Monson et al., 2006; Jeffreys et al., 2014).  Dropout rates for PE 
have ranged from 28-44% (Eftekhari et al., 2013; Jeffreys et al., 2014).  While dropout rates are 
clearly problematic for both protocols, both typically produce clinically significant 
improvements when treatment is adhered to over time.  
Both CPT and PE have shown great success in outcome research; thus, one logical 
research question involves whether one is more effective than the other. In a head-to-head 
comparison, CPT and PE were equally effective in treating PTSD and depression in female 
sexual assault survivors (Resick et al., 2002).  A 2010 study by Chard et al., found that veterans 
from the OEF-OIF era were more responsive to trauma-focused therapy than Vietnam era 
veterans (Chard, Schumm, Owens, & Cottingham, 2010).  A 2014 dissertation by Rutt replicated 
that CPT and PE are equally effective in reducing total PCL scores in veterans as well (Rutt, 
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2014). Thus, it is often left to the provider and client preferences which treatment should be used 
based on individual and contextual factors. 
Much is still unknown about what treatments effectively work for PTSD and why they 
work.  CPT and PE are considered evidence-based treatments for PTSD, but little is known about 
how these treatments impact neurochemical or other brain change aspects of clients.  It seems 
that these therapies target many of the same brain areas and result in similar desired behavioral 
changes. There are potential benefits of using a trauma-focused PTSD therapy with PCT 
Veterans due to the overlapping nature of symptoms associated with PTSD, TBI, and chronic 
pain.  The current proposed study will attempt to determine if CPT or PE is more effective at 
reducing PTSD scores as assessed using the PCL in a PCT Veteran sample.      
Summary and Limitations of the Literature 
 The polytrauma clinical triad which includes co-occuring diagnoses of PTSD, brain 
injury, and chronic pain as a growing area of concern for OEF/OIF/OND veterans.  Advances in 
technology such as improved body armor have saved countless lives during the current wars.  
This means that servicemembers are surviving injuries and traumas that they likely would not 
have during previous war eras.  Fields in medical and psychological interventions are striving to 
adapt and create new interventions to save and improve the lives of those who are surviving such 
injuries.  In the case of PCT, it is typical for individuals to receive multiple forms of care from 
interdisciplinary teams.  One part of that team usually involves a clinician trained in 
psychological interventions such as cognitive processing therapy or prolonged exposure for 
PTSD.   
 It has been hypothesized that in PCT, PTSD is metaphorically driving the bus or the 
reason why symptoms relevant to the experience of trauma, brain injury, and chronic pain persist 
 
 
- 44 - 
 
even when other interventions such as prescription medications for pain or mood are utilized.  
While managing symptoms of pain while addressing PTSD symptoms may be important, some 
believe that the first line of defense should be to attempt to reduce the cognitive load an 
individual carries while trying to live with their PTSD symptoms as well as their other co-morbid 
diagnoses.  There seems to be agreement in the literature that cognitive dysfunctions such as 
unworkable beliefs or other cognitive distortions are a theme that contributes to the persistence 
of symptoms in PCT patients.   
The current study seeks to advance the understanding of PCT by targeting PTSD 
symptoms through CPT and PE.  It is thought that if new and more effective or functional 
cognitive schemas can be adapted by patients to help reduce their PTSD symptoms that those 
schemas or skills may be transferable under a lesser degree of cognitive load once PTSD 
symptoms are alleviated to address the symptoms remaining which are associated with brain 
injury and/or chronic pain.   
Research Questions & Hypotheses 
This study was based on the following research questions and hypotheses: 
Research Question 1.  Are CPT and PE effective PTSD treatments for veterans with the PCT?   
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) within CPT and PE treatment conditions.  
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-II 
scores) within CPT and PE treatment conditions.  
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) within CPT and PE treatment conditions.  
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 Hypothesis 4: There will be no difference in post-treatment PTSD outcomes (AUDC 
scores) within CPT and PE treatment conditions.  
 Hypothesis 5: There will be no difference in post-treatment PTSD outcomes (DVPRS 
scores) within CPT and PE treatment conditions.  
Research Question 2. Is CPT or PE better as a treatment modality for veterans with the PCT? 
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions.  
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions.  
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time. 
 Hypothesis 4: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions.  
 Hypothesis 5: There will be no difference in post-treatment pain outcomes (DVPRS 
scores) between CPT and PE treatment conditions.  
Research Question 3.  Are there differences in outcomes by race/ethnicity between CPT and 
PE? 
 Hypothesis 1: There will be no differences within or between treatment groups when all 5 
symptom scales and race/ethnicity are analyzed simultaneously. 
 Hypothesis 2: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions by race/ethnicity.  
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 Hypothesis 3: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions by race/ethnicity.  
 Hypothesis 4: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time by race/ethnicity. 
 Hypothesis 5: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions by race/ethnicity.  
 Hypothesis 6: There will be no difference in post-treatment pain outcomes (pain scale 
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Chapter III  
Methods 
Based on the literature review presented, there is a clear and urgent need for further 
research on psychological interventions for the treatment of the polytrauma clinical triad (PCT) 
in veteran populations.  It is thought that by aiming to reduce symptoms associated with 
posttraumatic stress that clients may be better able to recover from other injuries such as those 
sustained from a traumatic brain injury (TBI) or chronic pain.   The two most commonly used 
trauma-focused evidence-based treatments (EBT’s) for posttraumatic stress disorder (PTSD) in 
the VA include cognitive processing therapy (CPT) and prolonged exposure (PE).  Although 
these interventions were not developed with the intention of being used specifically with PCT 
veterans, there may be benefits of using them with this population of patients who seek mental 
health services.   
The current study analyzed retrospective existing data from OEF/OIF/OND Veterans 
who served between September 11, 2001 and September 11, 2015 and met diagnostic criteria of 
having the polytrauma clinical triad.  The medical records of 2,173 veterans who met inclusion 
criteria for this study were reviewed.  Information such as age, race/ethnicity, gender, and branch 
of service as well as survey data including scores on the PCL-M, BAI, BDI-II, AUDC, and pain 
scale scores were collected.  The data were analyzed with the intention of looking for clinical 
outcomes as measured by changes in pre-treatment to post-treatment scores on the previously 
noted assessments.  The information gained from the current study will be useful for clinicians to 
make better informed clinical decisions when choosing between using CPT or PE for patients 
with the polytrauma clinical triad based on patient factors like race/ethnicity and baseline 
conditions such as anxiety and alcohol use.   
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The purpose of the present study is to examine the following:  
Research Question 1.  Are CPT and PE effective PTSD treatments for veterans with the PCT?   
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) within CPT and PE treatment conditions.  
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-II 
scores) within CPT and PE treatment conditions.  
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) within CPT and PE treatment conditions.  
 Hypothesis 4: There will be no difference in post-treatment PTSD outcomes (AUDC 
scores) within CPT and PE treatment conditions.  
 Hypothesis 5: There will be no difference in post-treatment PTSD outcomes (DVPRS 
scores) within CPT and PE treatment conditions.  
Research Question 2. Is CPT or PE better as a treatment modality for veterans with the PCT? 
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions.  
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions.  
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time. 
 Hypothesis 4: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions.  
 
 
- 49 - 
 
 Hypothesis 5: There will be no difference in post-treatment pain outcomes (DVPRS 
scores) between CPT and PE treatment conditions.  
Research Question 3.  Are there differences in outcomes by race/ethnicity between CPT and 
PE? 
 Hypothesis 1: There will be no differences within or between treatment groups when all 5 
symptom scales and race/ethnicity are analyzed simultaneously. 
 Hypothesis 2: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions by race/ethnicity.  
 Hypothesis 3: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions by race/ethnicity.  
 Hypothesis 4: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time by race/ethnicity. 
 Hypothesis 5: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions by race/ethnicity.  
 Hypothesis 6: There will be no difference in post-treatment pain outcomes (pain scale 
scores) between CPT and PE treatment conditions by race/ethnicity.  
Procedure 
 The study utilized retrospective data stored in the Corporate Data Warehouse (CDW), 
National Compensation and Pension Record Interchange (National CAPRI), and the Veterans 
Benefit Management System (VBMS) and was accessed through the VA Informatics and 
Computing Infrastructure (VINCI).  The data were analyzed from a secure remote platform.  The 
current study was exempt from requiring informed consent to access participants’ medical 
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records.  All procedures were approved by internal review boards of the VA Eastern Kansas 
Healthcare System and the University of Kansas Human Subjects Committee of Lawrence.  The 
data were analyzed using SPSS Version 24 and Microsoft Excel.  To protect confidentiality, all 
individually identifiable information was removed and data were stored on a secure VINCI drive 
that only the investigators had access to.   
Patient Selection.  The researchers requested data from the Department of Veterans 
Affairs (VA) Informatics and Computing Infrastructure (VINCI; U.S. Department of Veterans 
Affairs, 2014).  The purpose of VINCI is to provide researchers with access to VA data while 
ensuring Veterans’ privacy and data security.  The researchers requested data for approximately 
2,500 subjects who completed at least 2 Posttraumatic Stress Checklist’s (PCL-M) within a 6 
month period, and at least 2 of each of the following within a 6 month period: Alcohol Use 
Disorders Checklist (AUDC), Beck Anxiety Inventory (BAI), Beck Depression Inventory-II 
(BDI-II), and pain scale scores. Participants must have served only from September 11, 2001 to 
April 1, 2017, and their first service entry date was required to have been between September 11, 
2001 and September 11, 2015.  Veterans who had served prior to September 11, 2001 or had 
diagnoses related to psychosis were excluded from the study.  The original data request returned 
a cohort of 458,728 individuals who met diagnostic criteria.  Once the additional restricting 
criteria for assessments and service era dates were included, the potential electronic medical 
record files for individual patients decrease to 2,173 individuals.  
All participants included in the study had received either CPT or PE in individual therapy 
and meet the criteria of having PCT by evidence of diagnoses including PTSD, a history of TBI 
or concussive syndrome, and chronic pain. These criteria were checked during chart review and 
those with missing data were able to be rejected while maintaining adequate statistical power. 
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Files were reviewed using ICD-9-CM Codes related to PTSD, TBI or brain injury, and chronic 
pain using the codes that Cifu, Taylor, Carne, Bidelspach, Sayer, Scholten, and Campbell (2013) 
used.  Only participants who complete either the CPT or PE protocol were included in the study.  
Completion status was determined from clinical notes during chart review and is operationalized 
below.   
After gaining access to the VINCI database, researchers used the Statistical Package for 
the Social Sciences (SPSS) Version 23 to analyze the data.  Initially, descriptive statistics were 
used to account for patient factors such as age, gender, race/ethnicity, marriage status, and 
service connection rating.  Two-way ANOVAs were used to analyze the data to explore the 
hypothesized outcomes. The researchers considered the statistical findings after data analysis in 
context with other relevant information such as previous research findings when describing the 
findings of the current study.   
The initial cohort of potential participants was 458,728 distinct individuals that met the 
diagnostic criteria for inclusion in the study.  Out of these individuals, 29,888 had completed the 
PCL-M. 16,053 had completed both the PCL-M and BDI-II.  5,111 had completed the PCL-M, 
BDI-II, and BAI.  4,823 had completed the PCL-M, BDI-II, BAI, and AUDIT-C.  A final 
reduction in potential charts to review was done by removing individuals who had served prior to 
September 11, 2001, left the service and then re-entered the service after September 11, 2001.  
The final cohort only included veterans who had entered service between September 11, 2001 
and September 11, 2015 and had not served prior to September 11, 2001 so that the participants 
in this study would not have included veterans from any other eras except the Persian Gulf War 
and OEF/OIF/OND.  This left 2,173 distinct individuals who met diagnostic criteria and had 
completed the measures needed for this study without missing data.  Charts were randomly 
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assigned a number then reviewed at random until there were two equal groups.  One group 
contained 70 individuals who had participated in CPT and the other was a group of 70 who had 
participated in PE.  Using a third group as a control group was considered, but decided against 
during chart review because there were too many confounding variables such as having 
participated in another type of EBP for a mental health disorder and suicide attempts.  Chart 
review was then completed to fill in data about type of treatment (CPT or PE) and to report 
changes in pain scale scores.  The codes in the table below were used when requesting data on 
PCT patients based on Cifu et al.’s 2013 study. 
Polytrauma diagnoses and associated International Classification of Diseases- 9th Revision- 
Clinical Modification (ICD-9-CM) codes 
Diagnosis ICD-9-CM Code 
Traumatic Brain Injury 310.2, 800.0-801.9, 803.0-804.9, 850.0-854.1, 905.0, 907.0, 950.1-





     Back 





     Neck 
 
 
     Headache/Migraine 
 
721.3x-721.9x, 722.2x, 722.30, 722.70, 722.80, 722.90, 722.32, 
722.72, 722.82, 722.92, 722.33, 722.73, 722.83, 722.93, 724.xx, 
737.1, 737.3, 738.4, 738.5, 739.2, 739.3, 739.4, 756.10, 756.11, 
756.12, 756.13, 756.19, 805.4, 805.8, 839. 2, 839.42, 846, 846.0, 
847.1, 847.2, 847.3, 847.9  
 
721.0x, 721.1x, 722.0x, 722.31, 722.71, 722.81, 722.91, 723.xx, 
839.0, 839.1, 847.0 
 
346.x, 307.81, 784.0, 339.xx 
Table 1. PCT codes 
 
Participants 
Demographics. The mean age of participants was 36.264 years with the mode being 34 
years. Ages ranged from 26 to 54 years at the time their intervention began. The mean time in 
service was 35.129 months with a median of 33.50 months, and bi-modal of 14.0 and16.0 
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months. Time in service ranged from 6 months to 91 months. There were 135 males and 5 
females. Reported race/ethnicity were as follows: 77 white/Caucasian; 29 Black/African 
American; 15 Hispanic; 15 other/unknown; and 4 Asian/Pacific Islander. In the CPT group, there 
were: 36 Caucasian; 16 African American; 3 Asian/Pacific Islander; 11 Hispanic; and 4 
Other/Unknown.  In the PE group, there were: 41 Caucasian; 13 African American; 1 
Asian/Pacific Islander; 4 Hispanic; and 11 Other/Unknown.  50 participants were married, 80 
were single/never married, and 10 were separated or divorced. Percent Service Connected 
Disability Rating was also considered. The mean rating was 82.929, median was 90.000, and 
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Table 2. Demographic of sample and descriptive statistics. (N = 140) 
_________________________________________________________________________________ 
Variable     N  %  M  SD 
Sex 
 Male     135  96.4   
 Female        5    3.6 
Age (years)         36.26  6.08 
Race/Ethnicity 
 Caucasian    77     55 
  CPT    36  51.4 
  PE    41  58.6 
 African American   29  20.7 
  CPT    16  22.9 
  PE    13  18.6 
 Asian/Pacific Islander     4    2.9 
  CPT      3    4.1 
  PE      1    1.4 
 Hispanic    15  10.7 
  CPT    11  15.7 
  PE      4    5.7 
 Other/Unknown   15  10.7 
  CPT      4    5.7 
  PE    11  15.7 
Service Connection (% Rating)      82.93  19.02 
  0       0       0 
10       1      .7 
 20       1      .7 
 30       1      .7 
 40       5    3.6 
 50       5    3.6 
 60       8    5.7 
 70     17  12.1 
 80     27  19.3 
 90     23  16.4 
 100     52  37.1 
Service in Months        35.13  20.636 
Marital Status 
 Married    50  35.7 
 Single/Never Married   80  57.1 
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Figure 1. Age in years 
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Figure 2. Percent service connected 
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Figure 3. Service in months 
Independent Variables  
 Type of treatment (CPT or PE), age, gender, and marital status will be treated as an 
independent variables.  Race/ethnicity, time in service, and service connected rating will be 
considered independent variables as well.   
Completion Status.  Completion status was operationalized as a binary variable meaning 
that participates were either considered to have completed CPT or PE or had not.  Because there 
are several variations of the protocols and previous studies have found that the greatest amount 
of change occurs within the first 6 sessions of the CPT protocol, to be included as a “completer” 
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in this study participants had to have completed at least 6 sessions of individual CPT.  Yoder, 
Tuerk, Price, Grubaugh, Strachan, Myrick, and Acierno (2012) noted that some veterans improve 
rapidly during PE so in their study they defined PE completers has those who had completed at 
least 6 of the typical 12 sessions in the protocol.  To be more stringent, the current study defined 
PE completers as those who attended at least 8 sessions.  Patients who completed fewer than 6 
sessions of CPT or 8 sessions of PE were considered non-completers and were therefore 
excluded from this study.  Data was not collected on non-completers.  Some previous studies 
such as Rutt (2014) looked at data about veterans who do not complete the CPT or PE protocol 
and Rutt also included therapist factors.   
Symptom Changes Initial scores on the PCL-M, BAI, BDI-II, AUDIT-C, and pain scale 
score served as initial symptom severity measures for PTSD, anxiety, depression, alcohol use, 
and pain for each patient.  The final score for each of these measures used was the score that was 
closest to the date they completed their CPT or PE protocol. 
Age. Age was operationalized as the number of years old the patient was at the beginning 
of their CPT or PE treatment. Age was calculated using each patient’s date of birth and 
subtracting that from the date of first CPT or PE session.  
Treatment. The treatment modality for all patients was individual psychotherapy.  Only 
patients who participated in CPT or PE were included.  Patients were not excluded for being on 
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Race/Ethnicity.  Race/ethnicity was considered to be an independent variable and was 
divided into Caucasians, African Americans, Hispanics, and Other based on previous lines of 
research and the descriptive statistics observed in the current study.   
Dependent Variables 
 Pre and posttest scores on the PCL, BAI, BDI-II, AUDC, and pain scale scores were used 
as the dependent variables.   
 PCL-M.  The PCL-M is a self-report measure of PTSD symptoms that aligns with the 
Diagnostic and Statistical Manual of Mental Disorders 4th edition Text Revision (DSM-IV-TR) 
criteria for PTSD (Weathers, Litz, Herman, Juska, & Keane, 1993).  Although the DSM-5 is 
currently in use, because this is a retroactive study the previous edition of the DSM-IV-TR and 
PCL-M have been selected for use in this study.  The PCL contains 17 items that clients respond 
to on a 5-point Likert scale (1 = not at all; 2 = a little bit; 3 = moderately; 4 = quite a bit; 5 = 
extremely).  A total score is derived by summing all of the items.  Lower scores indicate less 
severe PTSD symptoms and higher scores indicate higher frequency or severity of PTSD 
symptoms.  Thus, decreases in PCL-M scores over time have routinely been considered 
indication of reductions in frequency or severity of PTSD symptoms.  The recommended cut-
score to warrant a PTSD diagnoses was proposed as 50 to minimize false positives (Weathers et 
al. 1993) although scores of 36 or higher warrant further assessment in Veteran populations.  To 
determine if a person has responded with improvements to treatment, the National Center for 
PTSD has recommended a decline of 5 points or more on the PCL while a decrease in 10 points 
would be considered clinically significant change.  According to Blanchard and colleagues, the 
internal consistency for the PCL is alpha = .97 and the test-retest reliability over one week is also 
high at (r = .96) (Blanchard, Jones-Alexander, Buckley, & Forneris, 1996).   
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Beck Anxiety Inventory (BAI).  The BAI is a self-report style screening measure for 
anxiety.  It consists of 21 items that measure subjective and somatic symptoms that are 
commonly experienced by individuals with anxiety.  Patients select a rating on a Likert style 
scale that best describes their symptoms.  The scale ranges from 0 “not at all” to 3 “severely”.  
Individuals are asked to only think about how their symptoms have been within the past week.  
Beck and Steer (1993) established that the internal validity for the BAI is excellent at α = .92 and 
its test-retest reliability is r = .75.  Palmer et. al (2014) tested the psychometric properties of the 
BAI with veterans with polytrauma and found internal reliability of α = .92.  The mean score for 
polytrauma veterans was 16.54 (SD = 11.25; range = 0 – 47) in Palmer et. al’s (2014) sample.  
Beck Depression Inventory-II (BDI-II).  The BDI-II was used as a screening measure 
to assess for depressive symptoms in the polytrauma clinic. The screening measure consists of 21 
items assessing affective, cognitive, and physiological symptoms associated with depression. 
The BDI-II is a self-report screening measure that asks the patient to evaluate symptoms based 
on a series of sentences (for each item) presented in ascending order from no symptoms (score of 
0) to severe symptoms (score of 3). The patient is asked to rate symptoms in the context of 
experiences within the last 2 weeks. The instrument has been demonstrated to have good 
reliability and validity.  Beck et al. (1996) reported that the BDI-II was found to have α = .92 for 
outpatients and α = .93 for college student samples and a test–retest reliability of r = 0.93 at one-
week with an internal consistency α=.91.  Palmer et al. (2016) researched the psychometric 
properties of the BDI-II for veterans with polytrauma and found α = .93 with a mean score was 
21.20 (SD = 11.76; range = 0 – 51).   
 Alcohol Use Disorders Identification Test (AUDIT-C).  The AUDIT-C is a validated 
three-item screen for alcohol misuse.   The AUDIT-C is one of the most commonly used alcohol 
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use screening tools in the VA that can help identify patients who are high-risk drinkers or may 
have an alcohol use disorders (i.e., alcohol abuse or dependence).  Alcohol use in previous 
studies has been defined by scores on the AUDIT-C.  AUDIT-C items assess the frequency and 
quantity of typical drinking and the frequency of heavy episodic drinking.  Patients respond 
using a Likert scale to three items: (1) how often they have a drink containing alcohol, (2) how 
many drinks containing alcohol they have in a typical day when drinking, and (3) how often they 
have six or more drinks on one occasion. AUDIT-C scores range from 0 to 12.  Higher scores 
equate to greater levels of severity.  Within the VA system, providers are notified by an 
electronic reminder to administer the AUDIT-C to all patients annually.  It may be given to 
patients multiple times per year to assess ongoing concerns related to alcohol use.  Previous 
studies have used the following ranges of scores to categorized patients into four risk groups: 
nondrinkers (score of 0), low-level drinkers (score of 1–4), moderate alcohol misuse (score of 5–
7), and severe alcohol misuse (score of 8–12).  Bush et al. (1993) reported that in men, scores 
equal to or greater than 4 on the AUDIT-C had a sensitivity of .86 and specificity of .72.  
Bradley et al. (2003) found in female veterans who reported scores equal to or greater than 3 had 
a sensitivity of .66 and specificity of .94.  Previous literature agrees that the AUDIT-C is a valid 
and reliable measure for assessing alcohol abuse or dependence.  
 Defense and Veterans Pain Rating Scale (DVPRS).  Pain scale scores were 
extrapolated during the clinical chart reviews. The pain scores used in the current study 
sometimes came from within the notes of the mental health provider, but sometimes were 
collected from the notes of medical providers that saw the patients in settings such as primary 
care at appointments that were closest to the start and end dates of either CPT or PE.  The VA 
has pushed to include pain as the 5th vital sign over the past decade or so.  While it has become 
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common practice for medical providers to ask patients to rate their pain at their appointments, it 
is still rare that mental health providers do so regularly.  Nevertheless, the vast majority of 
providers ask about pain using a 10 point rating scale that patients are familiar with regardless of 
the healthcare setting.  Patients who had clearly been asked to rate their current pain using a 10 
point scale were included in this study. 
The Department of Defense and VA adhere to the use of the Defense and Veterans Pain 
Rating Scale (DVPRS).  The DVPRS uses the 10 point numerical rating scale and each point has 
a written description in the form of a functional statement about the intensity of the pain.  For 
example, a “2” is “notice pain, does not interfere with activities” and a “7” is “[pain is] focus of 
attention, prevents doing daily activities”.  If patients are shown the DVPRS, it includes 6 
pictorial facial expressions matched to ranges of pain levels, is color coded, and has an alternate 
way to categorize the pain.  This alternate way includes the descriptors of mild pain being rated 
1-4, moderate pain as 5-6, and severe pain as 7-10.   
The DVPRS 2.0 has consistently been found to be both reliable and valid for assessing 
pain in veteran populations.  It does this by providing standard language and different modes to 
allow patients to communicate their pain levels to providers.  Polomano, Galloway, Kent, 
Brandon-Edwards, Kwon, Morales, and Buckenmaier (2016) evaluated the current version of the 
DVPRS 2.0 which is an updated version from the DVPRS 1.0.  When used with a sample of 
veterans that closely match the demographics of the current study, internal reliability was found 
to be Cronbach’s alpha = 0.871 and test-retest reliability was r = 0.637 to r = 0.774 when the 
additional 5 follow-up questions were used.  These questions were not included as part of the 
current study.  A qualitative component of Poloman et al.’s study found that 70.9% of 
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participants felt that the DVPRS was better than other pain rating scales they had been assessed 
using previously.   
Ethical Issues 
In the realm of clinical research, ethical issues are of the utmost importance.  The primary 
ethical issues that were managed in the present study involved protecting the confidentiality and 
privacy of patients and their records.  After approval from IRB processes, only the minimum of 
personally identifiable information (PII) was collected and remained within a secure VINCI 
server.   As soon as was possible, PII was removed from the data so that it could no longer be 
connected to individuals.  This was done to reduce the risk of breaching confidentiality.  This 
study also was granted an exemption of informed consent.  This was done because it would have 
been impractical to contact every potential participant to gain consent to use their records for 
chart review and could have had unintended effects if the individuals were currently in treatment.  
All individuals who utilize the VA healthcare system agree that their data may be used for 
research purposes.   
Some PII such as social security numbers and date of birth were required in order to 
access the patients’ charts.  Once the chart reviews were complete, social security numbers were 
replaced by a study identification number and the social security numbers were deleted.  Date of 
birth was used to calculate age to the nearest whole year.  Once this calculation was complete for 
all participants the date of birth information was deleted.   
Data Analysis 
This study used descriptive statistics and repeated measures ANOVA (RM-ANOVA), 
two-way RM-ANOVA, and two-way repeated measures MANOVA (RM-MANOVA) to analyze 
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the data.  The use of numerous t-tests were considered, but rejected as a means to reduce the 
potential of making type 1 errors.  Additionally, considerations to sample size and lack of 
random assignment to treatment groups to compare data from pre-treatment to post-treatment 
points in time helped to determine which statistical tests would provide the most power and 
appropriately answer the research questions.  Descriptive statistics were run to gain an 
understanding of who the participants in the sample were.  Information about age, race/ethnicity, 
gender, service connection rating, and time in service were evaluated by gathering frequencies, 
percentages, mean, median, mode, and range. Analyzing within and between group differences 
for CPT and PE using the pre and post scores on the PCL-M, BDI-2, BAI, AUDC, and pain scale 
scores were run through two-way RM-ANOVAs and RM-MANOVA.  Similar to t-tests, 
ANOVA is used to calculate the ratio of observed (actual) differences to differences expected 
due to chance.  Using the F ratio allowed the researcher to look at the variance between and 
within groups.  The current study only used pre and post-treatment data.  Therefore, spherocity 
did not need to be evaluated as it was not necessary to have homogeneity of variance or 
covariance in this case. A p-value of .05 or below was considered statistically significant based 
on standard procedures used in social sciences research.  Post-hoc analyses could not be 
conducted because only two treatment groups were used and at least 3 groups are needed.  Future 
studies may consider using a waitlist or treatment as usual control group so that additional levels 
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Chapter IV  
Results 
 Three main research questions were the foundation for this study.  The first question was 
geared at gaining an understanding of the effectiveness of CPT and PE overall for veterans with 
PCT.  This included looking at changes in symptoms related to PTSD, depression, anxiety, 
alcohol use, and pain.  The second research question that came out of the data was about looking 
at differences in PTSD symptom outcomes between CPT and PE.  The third research question 
meant to see if there were differences between and within CPT and PE on symptom outcomes by 
race/ethnicity.  While many other research questions certainly could be answered by this data, 
they would be best answered through follow-up studies with additional literature reviewed to 
support the rationale of further inquiry.  The remainder of this chapter will address the findings 
relevant to the current study’s research questions and proposed hypotheses.   
Research Question 1.  Are CPT and PE effective PTSD treatments for veterans with the PCT?   
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) within CPT and PE treatment conditions.  
The main effect within treatment groups was significant, F (1,138) = 1152.186, p =.000, ηp 
2 
= .893.  Patients in both groups showed statistically significant improvements in PTSD 
symptoms.  PTSD scores decreased in the CPT group from pretest (M=56.086, SE=1.175) to 
posttest (M=40.543, SE = 1.101). PCL-M scores decreased in the PE group from pretest 
(M=52.800, SE=1.175) to posttest (M=38.271, SE=1.101).  This indicated both statistically and 
clinically significant improvements (reductions in) total PCL-M scores which equates to a 
decrease in PTSD symptoms.  Most veterans in both treatment modalities started treatment with 
PCL-M scores in the moderate-severe or severe range, but by the end of treatment most were in 
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the moderate range.   Both CPT and PE are effective treatments for PTSD with veterans with 
PCT.   
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-II 
scores) within CPT and PE treatment conditions.  
The main effect within treatment groups was significant, F (1,138) = 265.978, p = .000, ηp 
2 = 
.658.  Patients in both groups showed statistically significant improvements in depression 
symptoms.  Depression scores decreased in the CPT group from pretest (M=32.700, SE=.939) to 
posttest (M=28.371, SE = .974). BDI-II scores decreased in the PE group from pretest 
(M=30.186, SE=.939) to posttest (M=18.229, SE=.974).  The initial mean BDI-II score in both 
groups were slightly above the cutpoint for severe depression symptoms.  Those in the PE group 
averaged larger decreases in their BDI-II scores than those in the CPT group, but the patients in 
the CPT group typically entered treatment with higher scores on the BDI-II.  Patients in the PE 
group had a mean decrease in depression of about 12 points going from severe range pre-
treatment to mild or moderate ranges post-treatment.  Those in the CPT group seemed to have 
more severe ratings of their depression and were more likely to have post-treatment BDI-II 
scores in the moderate or severe ranges.  Both CPT and PE are effective PTSD treatments for 
veterans with PCT and the results of this study suggest that using PE rather than CPT for PCT 
patients with depression may be clinically indicated. 
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) within CPT and PE treatment conditions.  
The main effect within treatment groups was significant, F (1,138) = 102.610, p = .000, ηp 
2 = 
.426.  Patients in both groups showed statistically significant improvements in anxiety 
symptoms. Observed initial scores on the BAI were higher for those who participated in CPT, 
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but both treatment groups experienced similar levels of pre to post treatment reductions in 
anxiety. Anxiety scores decreased in the CPT group from pretest (M=28.043, SE=1.346) to 
posttest (M=23.800, SE=1.080). Anxiety scores in the PE group decreased from pretest 
(M=25.286, SE=1.346) to posttest (M=20.957, SE = 1.080).  This finding is consistent with 
reports from many clinicians who have observed that patients with greater severity of anxiety 
symptoms may have a preference to engage in CPT rather than PE.  Higher rates of anxiety in 
PTSD patients are thought to correlate with increased rates of avoidance behaviors including 
avoidance of some of the elements of PE such as in vivo exposure exercises.  Nevertheless, in 
the current study patients in both treatment modalities had decreases in BAI scores however 
mean scores tended to remain in the moderate symptom range from pre-treatment to post-
treatment.  Based on the findings of the current study, clinicians could expect the severity of 
anxiety symptoms to decrease irrespective of their choice of PTSD treatment modality between 
CPT and PE.  
 Hypothesis 4: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) within CPT and PE treatment conditions.  
The main effect within treatment groups was significant, F (1,138) = 33.873, p = .000, ηp 
2 = 
.197.   Patients in both groups showed statistically significant improvements in alcohol use. 
Alcohol use scores decreased in the CPT group from pretest (M= 4.229, SD = 2.256) to posttest 
(M=3.686, SD = 1.620). AUDC scores decreased in the PE group from pretest (M=3.786, SD = 
2.173) to posttest (M= 3.300, SD = 1.663).  It must be noted that the psychometric properties for 
identifying patients with risky alcohol drinking patterns is different for males and females when 
using the AUDIT-C.  In men, a score of 4 or more indicates hazardous drinking, but a score of 3 
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or more in women indicates hazardous drinking.  The participants in the current study were 
nearly all men which may have influenced the findings.   
Most providers will not facilitate EBP’s for PTSD with patients who have moderate or more 
severe alcohol or substance use because of the impacts the substances have which detract from 
the likelihood of PTSD treatment being effective and may even increase the chances of 
exacerbating PTSD symptoms. Many PTSD patients use alcohol as a way to avoid experiencing 
intrusive memories Patients who engaged in CPT were more likely to have entered treatment 
with higher AUDIT-C scores which were slightly above the cutpoint for hazardous drinking in 
men.  Those in CPT had greater decreases in their AUDIT-C scores on average compared to PE 
participants.  Both CPT and PE are effective PTSD treatments that are likely to also result in 
decreases in reported alcohol use. 
 Hypothesis 5: There will be no difference in post-treatment pain outcomes (DVPRS 
scores) within CPT and PE treatment conditions.  
The main effect within treatment groups was significant, F (1,138) = 31.935, p = .000, ηp 
2 = 
.188.  Patients in both groups showed statistically significant improvements in pain.  Pain scale 
scores decreased in the CPT group from pretest (M= 2.843, SD = 1.304) to posttest (M=2.243, 
SD = 1.042). Pain scale scores decreased in the PE group from pretest (M=2.457, SD = 1.539) to 
posttest (M= 1.971, SD = 1.116).  Participants in both CPT and PE typically reported a mean 
DVPRS score in the mild range (1-4) at pre-treatment and again at post-treatment.  Qualitative 
subjective descriptions for the mild pain range include: (1) Hardly notice pain, (2) Notice pain, 
does not interfere with activities, (3) sometimes distracts me, and (4) Distracts me, can do usual 
activities.  Patients in both treatment modalities tended to have mild chronic pain levels of pain 
at pre-treatment and the mean DVPRS score for both groups decreased by about .5 points from 
 
 
- 69 - 
 
pre to post treatment.  This means that patients continued to experience mild chronic pain despite 
the statistically significant findings.  Although data was not collected for the current study on 
which patients were prescribed pain medication or were having their pain managed by another 
provider, this would be important information to include in future studies.  Both CPT and PE are 
effective PTSD treatments with PCT patients and are likely to also result in decreases in mild 
chronic pain ratings.  
Research Question 2. Is CPT or PE better as a treatment modality for veterans with the PCT? 
 Hypothesis 1: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions.  
The main effect for treatment was not significant, F (1,138)= 1.311, p =.254, ηp 
2 = .009.  
Both CPT and PE are equally effective PTSD treatments.  A One-Way RM-ANOVA with 
Bonferonni’s corrections compared the initial PTSD severity of those in the CPT group (M = 
56.08, SD = 10.1270) and PE group (M = 52.80, SD = 9.369).  There was not a significant 
difference between the groups and the post-treatment PTSD severity of those in the CPT group 
was (M = 40.54, SD = 10.299) and PE group (M = 38.27, SD = 7.982).  CPT participants 
averaged a decrease in PCL-M score of 15.54 points and PE participants’ average decrease was 
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Figure 4. PCL-M changes by treatment 
 Hypothesis 2: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions.  
The main effect for treatment was significant, F (1,138)= 58.360, p =.000, ηp 
2 = .297.  A 
One-Way RM-ANOVA with Bonferonni’s corrections compared the initial depression severity 
of those in the CPT group (M = 32.70, SD = 9.011) and PE group (M = 30.19, SD = 6.490).  
There was a significant difference between the groups and the post-treatment PTSD severity of 
those in the CPT group was (M = 28.37, SD = 10.113) and PE group (M = 18.23, SD = 5.528).  
PE patients improved 11.96 points on average and CPT patients improved 4.33 points on 
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average.  Those in the PE treatment condition had greater improvements or reductions in 
depressive symptoms compared to those in the CPT group.   
 
Figure 5. BDI-II changes by treatment 
 Hypothesis 3: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time. 
The main effect for treatment was not significant, F (1,138) = 2.799, p =.097, ηp 
2 = .020. A 
One-Way RM-ANOVA with Bonferonni’s corrections compared the initial anxiety severity of 
those in the CPT group (M = 28.04, SD = 11.789) and PE group (M = 25.29, SD = 10.717).  
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There was not a significant difference between the groups and the post-treatment anxiety severity 
of those in the CPT group was (M = 23.80, SD = 9.357) and PE group (M = 20.96, SD = 8.705).  
Those in the CPT treatment group had an average reduction in their BAI score of 4.24 points and 
those in the PE group had an average reduction of 4.32 points.  Reductions in anxiety symptoms 
were about the same in both treatment groups.   
 
Figure 6. BAI changes by treatment 
 Hypothesis 4: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions.  
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The main effect for treatment was not significant, F (1,138)= .105, p =.747, ηp 
2 = .001. A 
One-Way RM-ANOVA with Bonferonni’s corrections compared the initial alcohol use severity 
of those in the CPT group (M = 4.23, SD = 2.260) and PE group (M = 3.79, SD = 2.173).  There 
was not a significant difference between the groups and the post-treatment alcohol use severity 
of those in the CPT group was (M = 3.69, SD = 1.620) and PE group (M = 3.30, SD = 1.662).  
Those in the CPT treatment group had an average reduction of .54 points and those in the PE 
group had an average reduction rate of .49 points.  Reductions in alcohol use were about the 
same in both treatment groups.  
 
Figure 7. AUDIT-C changes by treatment 
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 Hypothesis 5: There will be no difference in post-treatment pain outcomes (pain scale 
scores) between CPT and PE treatment conditions.  
The main effect for treatment was not significant, F (1,138) = .354, p =.553, ηp 
2 = .003. A 
One-Way RM-ANOVA with Bonferonni’s corrections compared the initial pain severity of those 
in the CPT group (M = 2.84, SD = 1.304) and PE group (M = 2.46, SD = 1.539).  There was not 
a significant difference between the groups and the post-treatment pain severity of those in the 
CPT group was (M = 2.24, SD = 1.042) and PE group (M = 1.97, SD = 1.116).  Average 
reduction rates in pain scores in the CPT group was .60 points and .49 points for those in PE.  
Reductions in pain symptoms were about the same in both treatment groups.  
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Figure 8. DVPRS change by treatment 
Research Question 3.  Are there differences in symptom outcomes by race/ethnicity between 
CPT and PE? 
 Hypothesis 1: There will be no differences within or between treatment groups when all 5 
symptom scales and race/ethnicity are analyzed simultaneously.  
There was not a statistically significant interaction effect between race and type of 
intervention on the combined dependent variables, F (20, 418.845) = 1.178, p = .269; Wilks' Λ = 
.834. This is interpreted as there is not a statistically significant difference in treatment modality 
outcomes overall when all 5 symptom scales are considered at the same time and race/ethnicity 
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is accounted for.  The overall RM-MANOVA showed that within treatment groups there are 
differences in symptom outcomes by race that approached statistical significance F (20, 418.845) 
= 1.589, p = .052; Wilks' Λ = .785. This is interpreted as there is not statistical significance 
within each treatment group when all 5 symptoms and race/ethnicity are accounted for at the 
same time.  However, p = .052 approaches significance to a degree that it was decided that 
further interpretation included below would still hold clinical value.  
 Hypothesis 2: There will be no difference in post-treatment PTSD outcomes (PCL-M 
scores) between CPT and PE treatment conditions by race/ethnicity.  
Treatment effects within groups: F (1, 130) = .451, p = .503, ηp 
2 = .003.  There was not 
statistical significance on within subjects treatment effects. 
Treatment modality effects between subjects: F (1, 130) = .287, p = .593, ηp 
2 = .002.  There 
was not statistical significance between subjects in different treatment modalities. 
Race effects between subjects: F (4, 130) = .567, p = .687, ηp 
2 = .017.  There was not 
statistical significance between subjects by race. 
Treatment modality by race interaction effects: F (4, 130) = 1.374, p = .246, ηp 2 = .041.  
There was not statistical significance of interaction effects between treatment modalities by race. 
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Figure 9. PCL-M changes by race/ethnicity in CPT 
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Figure 10. PCL-M changes by race in PE 
 Hypothesis 3: There will be no difference in post-treatment depression outcomes (BDI-2 
scores) between CPT and PE treatment conditions by race/ethnicity.  
Treatment effects within groups: F (1, 130) = 27.512, p = .000, ηp 
2 = .175.  There was 
statistical significance on within subjects treatment effects.   
Treatment modality effects between subjects: F (1, 130) = 5.186, p = .024, ηp 
2 = .038.  There 
was statistical significance between subjects in different treatment modalities.   
Race effects between subjects: F (4, 130) = .499, p = .773, ηp 
2 = .014.  There was not 
statistical significance between subjects by race. 
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Treatment modality by race interaction effects: F (4, 130) = .308, p = .872, ηp 
2 = .009.  There 
was not statistical significance of interaction effects between treatment modalities by race. 
 
Figure 11. BDI-II changes by race in CPT 
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Figure 12. BDI-II changes by race in PE 
 Hypothesis 4: There will be no difference in post-treatment anxiety outcomes (BAI 
scores) between CPT and PE treatment conditions. Both treatments will result in 
significant reduction in anxiety symptoms over time by race/ethnicity. 
Treatment effects within groups: F (1, 130) = 4.094, p = .045, ηp 
2 = .031.  There was 
statistical significance on within subjects treatment effects.   
Treatment modality effects between subjects: F (1, 130) = .710, p = .401, ηp 
2 = .005.  There 
was not statistical significance between subjects in different treatment modalities. 
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Race effects between subjects: F (4, 130) = .446, p = .775, ηp 
2 = .014.  There was not 
statistical significance between subjects by race. 
Treatment modality by race interaction effects: F (4, 130) = .248, p = .911, ηp 
2 = .008.  There 
was not statistical significance of interaction effects between treatment modalities by race. 
 
Figure 13. BAI changes by race in CPT 
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Figure 14. BAI changes by race in PE 
 Hypothesis 5: There will be no difference in post-treatment alcohol use outcomes (AUDC 
scores) between CPT and PE treatment conditions by race/ethnicity.  
Treatment effects within groups: F (1, 130) = 1.157, p = .284, ηp 
2 = .009.  There was not 
statistical significance on within subjects treatment effects. 
Treatment modality effects between subjects: F (1, 130) = .6.387, p = .013, ηp 
2 = .047. There 
was statistical significance between subjects in different treatment modalities. 
Race effects between subjects: F (4, 130) = .1.434, p = .226, ηp 
2 = .042. There was not 
statistical significance between subjects by race. 
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Treatment modality by race interaction effects: F (4, 130) = 3.072, p = .019, ηp 
2 = .086.  
There was statistical significance of interaction effects between treatment modalities by race.   
 
Figure 15. AUDIT-C changes by race in CPT 
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Figure 16. AUDIT-C changes by race in PE 
 Hypothesis 6: There will be no difference in post-treatment pain outcomes (pain scale 
scores) between CPT and PE treatment conditions by race/ethnicity.  
Treatment effects within groups: F (1, 130) = .182, p = .670, ηp 
2 = .001.  There was not 
statistical significance on within subjects treatment effects. 
Treatment modality effects between subjects: F (1, 130) = .637, p = .426, ηp 
2 = .005.  There 
was not statistical significance between subjects in different treatment modalities.  
Race effects between subjects: F (4, 130) = .499, p = .736, ηp 
2 = .015.  There was not 
statistical significance between subjects by race.  
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Treatment modality by race interaction effects: F (4, 130) = .870, p = .484, ηp 
2 = .026.  There 
was not statistical significance of interaction effects between treatment modalities by race. 
 
Figure 17. DVPRS changes by race in CPT 
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Chapter V  
Discussion 
The final chapter of this dissertation will describe and summarize the main findings of 
this study.  The results from statistical analyses will be discussed and compared to findings of 
previous literature.  Additionally, scientific issues such as validity, potential future directions for 
research, and implications for clinical endeavors will be highlighted.   
Summary of the Findings 
Perhaps the most important finding of the current study is that both CPT and PE are 
effective treatments of PTSD for OEF/OIF/OND veterans with PCT.  Furthermore, both 
treatments also demonstrated added benefits of reducing other commonly co-occurring 
symptoms including depression, anxiety, alcohol use, and pain.  One interesting finding that was 
found in the current study is that the patients with higher initial mean PCL-M scores were more 
likely to participate in CPT than PE, but patients in both treatment groups had very similar 
decreases in total PCL-M scores at post-treatment which were statistically and clinically 
significant. The average change in PCL-M score for the CPT group was 15.543 points. Those in 
the PE group averaged a 14.529 decrease in PCL-M score.  It is important to note than any 
change on the PCL-M greater than 10 points is considered clinically significant change (Monson 
et al., 2008; National Center for PTSD, 2014).  This finding is consistent with previous literature 
that has demonstrated that not only are completed protocols of CPT and PE both effective 
empirically based treatments for PTSD, but both are about equally effective at reducing PTSD 
symptoms (Rutt, 2014).    
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The third research question explored whether there were differences in treatment 
outcomes for PTSD symptoms using the PCL-M between treatment groups by race/ethnicity.  
Consistent with previous findings, no statistically significant differences between groups by race 
were found.  Both CPT and PE seem to be effective at treating PTSD with racially and ethnically 
diverse patient populations.  Possibly worthy of additional study was the observation that there 
were more within group variations by race/ethnicity in the PE group than in the CPT group.  
Consistent with Rutt (2014), the current study found that Hispanic veterans endorsed higher 
initial PCL-M scores compared to other racial/ethnic groups.  The current study also agreed with 
Tuerk et al. (2011) that Caucasian and African American veterans do not have significantly 
different outcomes in PE and that overall, race was not a significant predictor of PTSD 
symptoms.  Future studies may seek to include a component that specifically looks more in depth 
at cultural factors that are relevant to the components of PE.   
Findings in the current study indicated that there are statistically significant differences 
between CPT and PE in regards to outcomes for depression. BDI-2 scores for the CPT group 
decreased 4.33 points while scores decreased 11.96 points on average for the PE group.  Those in 
the CPT group entered treatment with an average of about 2.5 points higher on the BDI-2.  In 
other words, patients entered both treatment modalities with relatively the same levels of 
depression.  It is notable that those who completed PE were more likely to have pre-treatment 
BDI-2 scores in the severe depression range which by the end of treatment were in the mild or 
moderate range.  Those who completed CPT were more likely to start with moderate to severe 
depression and still have moderate depression at the end of treatment.  Patients in the PE group 
had greater relief of depressive symptoms than those in the CPT group.  The finding that those in 
the PE group had significantly greater decrease in depressive symptoms is surprising because 
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CPT grew out of CBT which is and EBP for depression.  Further research on the use of CPT and 
PE for veterans with co-occurring PTSD and depression is worthy of further investigation.  The 
results of the current study suggest that using PE rather than CPT for patients with severe 
depression is worthy of consideration.  
The third researcher question focused on looking at between and within treatment 
differences by race on the symptom measures.  Within the CPT group, Caucasians, Hispanics, 
and Other/Unknown groups had the largest decreases in depression symptoms.  This suggests 
that CPT may improve depressive symptoms to a larger degree for those three groups than for 
African Americans and Asian/Pacific Islanders.  Changes in BDI-2 scores by race in the PE 
group were about the same for all race/ethnicity groups except for Asian/Pacific Islander.  There 
was only 1 Asian/Pacific Islander patient in PE group which leads to there being limited 
inferences that can be made about changes in depression for that racial/ethnic group from this 
study. In general, the results observed from the current study offer preliminary evidence that both 
CPT and PE are effective PTSD interventions that are likely to also lead to reductions in 
depressive symptoms.  
The current study found that both CPT and PE were effective at reducing anxiety.  It was 
observed that initial scores on the BAI were higher by 2.76 points for those who participated in 
CPT compared to PE.  Statistical analysis found that both treatment groups experienced similar 
levels of pre to post treatment reductions in anxiety.  Those who participated in CPT typically 
entered treatment with moderate anxiety and completed treatment still in the moderate anxiety 
range.  However, those in the PE group began treatment with slightly lower, but still moderate, 
levels of anxiety on average yet at the completion of PE were more likely to be in the low 
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anxiety range.  Veterans in the CPT group averaged a decrease on the BAI of 4.24 points.  
Veterans in the PE group averaged a decrease on the BAI of 4.33 points.  
When looking at the treatments with race included as a factor, Hispanics in the CPT 
group had much higher mean BAI scores than all other racial/ethnic groups at pre-treatment, but 
had similar point reductions in anxiety by post treatment.  Hispanics were most likely to enter 
treatment with severe anxiety in the CPT group.  In the PE group, the Asian/Pacific Islander 
individual entered treatment with the highest BAI score, followed by those in the 
Other/Unknown category.  Follow up research may consider studying why Hispanics may enter 
CPT with higher levels of anxiety than other racial groups.  Additionally, future research may 
ask why Asian/Pacific Islanders may engage in PE with higher anxiety rates and also have the 
greatest relief of anxiety 
Additional research that includes qualitative information from both patients and clinicians 
who are deciding between the use of CPT and PE as treatment options would be a recommended 
direction for further study.  Many clinicians and patients have noted that the anxiety, fear, and 
desire to avoid talking in great detail about traumatic experiences and memories is one reason 
why patients with higher initial anxiety may choose to engage in CPT rather than PE.  However, 
the findings of this study may provide some evidence for the benefit of using PE with patients 
who are anxious.  
It was noted that average AUDC scores decreased for veterans in both treatment groups.  
There were not enough female veterans in the current study to analyze if gender differences 
existed for changes in alcohol use, but this could be included in future studies to gain valuable 
information.    Both treatment groups had average decreases of about .5 points on the AUDC.    
Those in the CPT group were more likely than those in the PE group to enter treatment with 
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higher AUDC scores greater than 4 which in males indicates a greater likelihood of alcohol 
abuse or dependence.   Those in the PE group entered treatment more likely to disclose safer 
levels of alcohol use (scores below 4 on the AUDC).  Not surprisingly, AUDC scores in the PE 
group showed less of a reduction at post-treatment likely due to the fact that patients were 
already more likely to not have problematic drinking habits than patients in the CPT group.  
One surprising finding in the CPT group was that Asian/Pacific Islanders were most 
likely to endorse the highest mean scores on the AUDC.  This group was followed by Hispanics 
and then Caucasians in order of heaviest alcohol use discloser at pre-treatment screening.  These 
three groups had mean pre-treatment AUDC scores usually between 5 and 6.  They also had the 
greatest reduction in mean AUDC scores by post-treatment, however they were still likely to 
endorse lower levels of problematic drinking habits with post-treatment mean AUDC scores 
around 4.  In the PE group, Other/Unknown and African American racial/ethnic groups endorsed 
the highest mean AUDC scores at pre-treatment which tended to be mean scores between 4 to 5.  
At post-treatment, these two groups typically had mean AUDC score reductions of about 1 point. 
Caucasians, Hispanics, and the Asian/Pacific Islander in the PE group had almost no changes in 
their mean AUDC scores from pre to post treatment.  It is likely that CPT is more likely to 
correlate with or result in greater reductions in alcohol use than PE when patients screen positive 
for hazardous drinking habits.  
Both CPT and PE participants reported that their pain as reported on the DVPRS 
decreased by about 1 point from pre to post treatment.  The majority of participants entered 
treatment reporting mild pain which was rated between 0-4 on a 10 point scale, the DVPRS.  
Those in the CPT group tended to have pain scores that were about .5 point higher than patients 
in the PE group.  Although data was not collected on medications prescribed, it was noted during 
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chart review that many patients were already involved in other forms of pain management such 
as by prescription medication or physical therapy.  Future research on the relationship and 
treatment of pain throughout the recovery process from mental health conditions like PTSD, 
depression, anxiety, and substance use is an area lacking in research.  There were also some 
concerns brought to light that when assessing pain it may be important to specifically 
differentiate pain ratings for emotional versus physical pain which the DVPRS does not 
explicitly do.  
When looking at changes in pain within and between treatment groups by race, the results 
were mixed to say the least.  In the CPT group, there were decreases in pain for all racial/ethnic 
groups except for the Hispanic group reported no change in their mean DVPRS scores. Other 
racial groups in the CPT group reported decreases in pain between .5 to about 1 point from pre to 
post treatment.  In the PE group, African Americans and Hispanics reported the largest decreases 
in pain of about 1 point.  A general interpretation of these results is that CPT seems to be more 
effective in the current study at reducing pain scores, except for Hispanics for which PE may be 
more effective.  
The main summary of the results of this study are that both CPT and PE are effective 
PTSD treatments for veterans with the PCT.  It is critical to consider contextual and patient 
factors like race/ethnicity in addition to the constellation of additional symptoms explored in the 
current study that patients endorse when discussing treatment options between CPT and PE.  
Furthermore, limitations that patients may have because of their TBI may impact which PTSD 
treatment protocol is possible to use or if adjustments to the protocol may need to be considered 
for issues such as physical or sensory deficits.  Providers who choose to use either CPT or PE 
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with OEF/OIF/OND veterans with PCT can feel confident that either protocol will be effective 
treatment for PTSD as well as other symptoms this population frequently endorses.  
Limitations 
Validity This study intended to investigate or predict clinical outcomes.  In essence, this 
could be considered a type of effectiveness study that looked at pre to post treatment changes.  
This study aligns with a quasi-experimental design because existing data was retrospectively 
analyzed.  Because data had already been collected prior to this study, participants had not been 
randomly assigned to treatment conditions or groups which is a limitation to internal validity.  
Random assignment would increase the validity of this study by reducing selection bias.  
Initially, this study hoped to include a control group of veterans who met diagnostic criteria for 
PCT and had completed the necessary assessments.  However, it quickly became apparent that 
those who would have been included in the control group tended to be extreme outliers with 
regards to symptoms severity, especially substance use and suicidal ideation, and many were 
noted to have history of psychotic related episodes.  Previous studies that have included control 
groups have found absolute efficacy of both CPT and PE which is congruent to what the current 
study found as well.  The participants in this study were also 95% male and 5% female and not 
evenly distributed in the two treatment modalities by race.  This greatly limits what could be 
inferred about female veterans or differences by race/ethnicity with PCT who engage in either 
CPT or PE. Overall, this study has a few design flaws that could be addressed in through 
research design methodology or other statistical adjustments in future research.   
An area of strength for the current study is that it uses retrospective clinical data collected 
from the records of real veterans who sought services throughout the US at VA healthcare 
settings over a span of more than 10 years.  Using data collected from real-world clinical settings 
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increases the current study’s external validity.  The researcher included 140 veterans, 70 in CPT 
and 70 in PE, in the current study to ensure adequate statistical power.  The results of this 
research have generalizability to OEF/OIF/OND veterans with similar demographic backgrounds 
and mental health diagnoses as those included in the current study.   
Unaccounted for variables. While some variables were accounted for in this study that 
previous literature may not have included, there are more variables that could have been 
explored through additional analyses which may be able to be completed through additional 
requests or chart review run on the existing dataset.  For example, pharmacotherapy and length 
of duration (i.e. in months) was not controlled for in this study, but should be addressed in future 
research.  Other data that could produce helpful findings may include employment and disability 
status beyond service connection rating.  It is also recommended that personality factors, trauma 
severity such as complex chronic trauma, adhering to homework, time between trauma and 
initiation of therapy, and other motivational factors be considered.  It may be useful to consider 
differentiating by level and type of brain injury as well as therapist factors too such as type of 
degree, level of training, and years of experience.  Future research may benefit from 
interdisciplinary data that may be relevant to factors such as genetics or other neurological and 
biological facets of the diagnoses that were included in this study including but not limited to 
information from imaging studies, vital signs, and medical labs.  
Testing effects and limitations of self-report measures.  The use of self-report style 
measures is a limitation of this study.  Effort was taken to ensure that valid and reliable self-
report measures were used, but only using self-report measures may have limited the data.  Some 
literature has found that self-report measures may be biased because of response styles that 
typically err on the side of social desirability.  It is possible that some participants may not have 
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fully disclosed the most accurate severity levels of their symptoms.  This could be due to a 
variety of reasons, but one example of an issue that is a problem within VA settings is that 
patients who receive service connected benefits may not be motivated to report improvements in 
symptoms if those improvements could mean a reduction in service connected disability benefits.  
Future studies may want to consider including qualitative analysis of other forms of data such as 
objective measures, clinical notes, or informational interviews completed by family members or 
friends.   
Implications for Practice 
 The current study has a higher level of external validity which is beneficial when 
generalizing the findings into real-world practice settings when trauma-focused therapies such as 
CPT and PE are conducted by mental health practitioners with OEF/OIF/OND veterans with 
PCT.  The findings indicate and are consistent with previous literature that CPT and PE are both 
effective in treating PTSD.  The current study extends the previous literature to include some 
evidence for the use of CPT and PE with PCT veterans, especially those who are current war-era 
male veterans with PCT.   Additionally, this research looked into the records of patients with 
multiple co-occurring mental health conditions beyond PTSD including depression, anxiety, 
alcohol use, and pain to gain insight into how CPT and PE may be beneficial to those who 
present to therapy with multiple sets of symptoms.  This study might also serve to point out to 
clinicians that assessing for common symptoms, like those measured in this study, are important 
to consider including at least at the time of screening before engaging in treatment to ensure one 
is making the best clinical recommendations for patients and again at post-treatment to greatly 
increase the possibility of gaining research on areas of clinical concern.  
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 Other relevant clinical issues that stood out during chart review included high therapy 
drop-out rates for OEF/OIF/OND veterans with PCT.  This finding is consistent with reports 
from previous literature that a large percentage of veterans do not complete either PE or CPT 
protocols and tend to drop out of therapy before the 6th session if there has been little or no 
improvements on PCL scores. The results of this study could be communicated to patients to 
provide them with an understanding of how much improvement in certain symptoms related to 
PTSD, depression, anxiety, alcohol use, and/or pain they might expect if they complete the 
treatment protocol.  The idea of sharing clinical outcome data with patients is consistent with the 
first idea about common factors that Jerome Frank’s book, Persuasion and Healing, points out.  
Frank (1961) wrote about 4 common elements or factors to effective psychotherapy:  (1) an 
expectation that treatment will work or help to alleviate symptoms (2) there is a therapeutic 
relationship between therapist and patient (3) the treatment contains a rationale that includes an 
explanation for the symptoms being experienced and describes a ritual (treatment) for healing 
those symptoms, and (4) both the patient and therapist adhere to and actively participate in the 
treatment’s protocol.  With the above reference in mind, it is logical that both CPT and PE would 
be effective treatments for PTSD and other mental health disorders with overlapping symptoms.  
Conclusion 
 The results of this study are generally in agreement with and extend the current literature 
regarding the effectiveness of CPT and PE.  Both of these interventions consistently demonstrate 
improvements in PTSD symptoms over time.  Furthermore, these treatments show promise for 
helping to reducing symptoms that commonly co-occur with PTSD such as depression, anxiety, 
alcohol use, and pain.  While chart review conducted during the current study revealed that drop-
out rates continue to be problematic for both therapies investigated, the overall findings that both 
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CPT and PE are effective in reducing PTSD symptoms equally well across multiple racial and 
ethnic categories is encouraging.  Clinicians who choose to be trained in, use, and adhere to the 
protocols of CPT and/or PE can feel confident that either of these EBP’s for PTSD are likely to 
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